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Calf diarrhoea remains the most important cause of economic loss to both dairy and 
beef cattle industries worldwide, with approximately 50% of deaths among weaning 
calves resulting from diarrhoeal disease.  Complex etiopathogenesis involving the 
infection of one or multiple pathogens, as well as other non-infectious factors such as 
the environment and nutrition, contributes to its devastating effects.  Astroviruses 
(AstVs) and Kobuviruses (KoVs) are two single-stranded, positive-sense RNA 
viruses previously detected in healthy and diarrhoeic calves.  AstV was identified in 
healthy and diarrhoeic calves in similar proportions, while KoV was predominantly 
associated with diarrhoeic individuals. 
In order to investigate the KoV strains found in diarrhoeic calves, the full genome of 
KoV from a diarrhoeic calf was sequenced.  This KoV was then compared with the 
bovine U-1, porcine KoV and Aichi virus strains.  Specifically-designed PCRs were 
used to target the full KoV genome of positive samples, and amplicons were cloned 
to allow the internal sequencing of one single KoV detected among possible mixed 
infections.  Upon assembly of the genome sequences, some animals were found to be 
co-infected with multiple KoVs.  The main region of diversity, the VP1 (capsid) 
region, was amplified from multiple samples to determine the diversity of KoV in 
Scotland.  The genome sequenced in this study will be used to produce an infectious 
clone for future challenge studies to establish the potential role of bovine KoV in calf 
diarrhoea. 
Another aspect of the study was to explore the diversity and epidemiology of AstV in 
diarrhoeic and healthy calves by capsid gene analysis.  As the AstV capsid protein is 
the major target of host antibody production, a serological test for AstV infection 
could then be developed.  Following amplification of AstV capsid genes by PCR, 
phylogenetic analysis identified 4 lineages from which capsids from 2 of these 
lineages were successfully cloned ready for use in the baculovirus expression system.  
This information and the expression plasmids containing representative AstV capsid 
genes can then be used to develop serological tests for AstV, enabling estimation of 









Calf diarrhoea remains the most important cause of economic loss to both dairy and 
beef cattle industries worldwide, with approximately 50% of deaths among weaning 
calves resulting from diarrhoeal disease.  The complex interactions between multiple 
pathogens (including viruses, bacteria and parasites) contribute to the fatalities 
associated with calf diarrhoea.  AstV and KoV have both been previously detected in 
calves suffering with diarrhoea.  AstV have been identified in healthy and diarrhoeic 
animals, while KoV have been predominantly found in diarrhoeic animals.  Further 
characterisation of both of these viruses is required to determine the role they each 
play in diarrhoeal disease, either as a primary pathogen or a co-factor for infection. 
The aims of this project were to investigate the diversity of bovine AstV and bovine 
KoV within the samples and others taken from the GenBank database.  In terms of 
bovine KoV, a full genome was sequenced from an infected calf, which is the first 
bovine KoV to be sequenced from an animal rather than cell culture.  For the AstV, 
genes known to be involved with pathogenicity of the virus and interact with the 
animal’s immune system, were also sequenced.  This collection of AstV sequences 
were then both compared with each other, and other known sequences in the 
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1.1  Calf diarrhoea 
Diarrhoea in young calves remains the most important cause of economic loss to 
both dairy and beef cattle industries worldwide, despite technological improvements 
in animal facilities and herd management (Cho and Yoon, 2014).  In 2007, the U.S. 
dairy industry reported 57% of unweaned heifer deaths were due to diarrhoeal 
disease, with the majority of calves under 1 month old (USDA, 2007).  A similar rate 
of 53.4% deaths for dairy calves due to calf diarrhoea was also recently reported in 
South Korea (Hur et al. 2013).  
Calf diarrhoea has a complex etiopathogenesis encompassing infectious and non-
infectious pathogens, including infection by one or multiple pathogens, and non-
infectious factors such as environment, management practices and nutrition 
(Blanchard, 2012).  Causative pathogens include a range of viruses, bacteria and 
parasites with the most important in the UK being coccidia, rotavirus, coronavirus, 
enterotoxigenic strains of Escherichia coli and Cryptosporidium parvum (Takiuchi et 
al. 2006; Foster and Smith 2009; Cho and Yoon, 2014).  Other viral pathogens such 
as  bovine torovirus, bovine AstV and bovine KoV have been associated with calf 
diarrhoea, although the extent of their contributions to pathogenesis are still to be 
determined (Khamrin et al. 2008; Gülaçti et al. 2014; Candido et al. 2015).  
There are a limited number of longitudinal studies of enteric virus infections in calves 
performed, and most of these studies only investigated one enteropathogen.  This 
makes defining the relationships between pathogens in co-infections challenging 
(Takiuchi et al. 2006; Tse et al. 2011; Gülaçti et al. 2014; Ribeiro et al. 2014).  The 
Coura et al. (2015) study is one of the few studies to investigate the epidemiology of 
enteric disease associated with Salmonella spp., enterotoxigenic strains of 
Escherichia coli, rotavirus and coronavirus infections in calves up to 70 days old in 
one dairy herd.  It identified a series of complex interactions taking place between 
pathogens and multiple internal and external factors throughout infection.  In order to 
establish the roles of individual pathogens within calf diarrhoeal disease, the 
identification of new or previously undetected pathogens is crucial.  More studies on 
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novel pathogens are required to understand the extent of pathogen interactions and 
environmental factors, with the aim of providing preventative and control strategies 




1.2.1  Background to kobuviruses 
 
1.2.1.1 Kobuvirus 
The first KoV to be discovered was Aichi virus in Japan in 1989.  It was isolated 
from faecal samples of human patients suffering from non-bacterial shellfish-
associated gastroenteritis (Yamashita et al. 1991).  In 1997, complete genome 
sequencing and phylogenetic analysis of this virus confirmed it to be a new member 
of the Picornaviridae family, with just 15-36% amino acid homology to those of 
other viruses in the family (Yamashita et al. 1991; Yamashita et al. 1998).  It was 
classified into a new genus of Picornaviridae called Kobuvirus, the name kobu 
(meaning ‘bump’ or ‘knob’ in Japanese) coming from the morphological appearance 
of the virions observed under an electron microscope (King et al. 1999).  
 
Figure 1: Unrooted neighbour-joining tree of the Picornaviridae family, based on a P1 capsid 
region comparison (Dubovi and MacLachlan, 2010). 
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The Picornaviridae family includes several important animal and human pathogens 
with a range of host species, such as foot-and-mouth disease virus and poliovirus, 
making picornaviruses an interesting family to study (see Figure 1) (Yamashita et al. 
2000; Hughes, 2004).  The kobuvirus genus currently comprises of six accepted or 
proposed species with canine KoV, murine KoV and ovine KoV being added most 
recently (Sweeney et al. 2012).  KoVs are divided into three Aichivirus species - A, 
B and C.  The distinction criteria for Aichivirus species are the following: viruses 
must share a greater than 70% amino acid identity in the polyprotein and P1 region 
(see Figure 3); share a greater than 80% amino acid identity in 2C and 3CD; and 
share a common genome organisation.  Aichivirus A includes Aichi virus, murine 
KoV, canine KoV and feline KoV (Cho et al. 2015); Aichivirus B includes bovine 
KoV, ovine KoV and ferret KoV (Cho et al. 2015); Aichivirus C includes porcine 
KoV (Ribeiro et al, 2013).  These species groups can be seen below in Figure 2. 
 
Figure 2. Phylogenetic grouping of the three species in the Kobuvirus family.  The red box 





















Recently, numerous other KoVs have been detected in a range of mammalian and 
avian, wild and domestic animals.  KoV has been present or associated with enteric 
disease in all the hosts indicated below in Table 1. 
Table 1: The first detection information of mammalian KoVs.  
Species Detection Reference 
Human (Aichi virus) 1989 Yamashita et al. 1991 
Cow 2003 Yamashita et al. 2003 
Pig 2008 Reuter et al. 2008 
Sheep 2010 Reuter et al. 2010 
Insectivorous bat 2010 Li et al. 2010 
Mouse 2011 Phan et al. 2011 
Dog 2011 Kapoor et al. 2011 
Goat 2012 Lee et al. 2012 
Cat 2013 Chung et al. 2013 
Ferret 2013 Smits et al. 2013 
Fox 2014 Bodewes et al. 2014 
Norway rat 2014 Firth et al. 2014 
Roe deer 2015 Di Martino et al. 2015 
European roller (bird) 2015 Pankovics et al. 2015 
Golden jackal 2015 Olarte-Castilloa et al. 2015 
Side-striped jackal 2015 Olarte-Castilloa et al. 2015 
Spotted hyena 2015 Olarte-Castilloa et al. 2015 
 
 
1.2.1.2 Bovine kobuvirus 
Following the discovery of Aichi virus, bovine KoV was detected for the first time in 
2003 as a cytopathic agent in a Vero cell culture medium.  Yamashita and colleagues 
(2003) explained the calf sera used in the medium had been contaminated with virus 
from the faeces of an infected animal.  The virus, termed U-1 strain, was found to be 
different from Aichi virus since it reacted with antibody raised to Aichi virus by 
ELISA, but could not be neutralised by Aichi virus antisera.  Antibodies against U-1 
6 
 
were not detected in human, monkey, pig, horse, dog or cat sera samples, compared 
to the bovine sera in which 60% of individuals were positive for neutralising 
antibodies (Yamashita et al. 2003). 
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1.2.2  Genome structure and genetic diversity 
1.2.2.1  Genome structure 
KoVs are small, spherical, non-enveloped viruses with a single-stranded, positive 
sense RNA genome between 8.2 and 8.4Kb in size (Yamashita et al. 2003; Reuter et 
al. 2009).  The genome encodes a polyprotein (approximately 2400 aa) which 
undergoes a cleavage cascade to obtain the active viral proteins (Yamashita et al. 
1998).  These predicted cleavage sites occur between a glutamine residue and 
another amino acid, commonly glycine, alanine or threonine, and are similar to those 
found in other picornaviruses.  Viral proteins include a non-structural protein (L), 
three structural proteins (VP0, VP3 ad VP1), and seven non-structural proteins (2A, 
2B, 2C, 3A, 3B, 3C and 3D), of which the VP1 capsid protein has been found to be 
the most immunogenic (Chang et al. 2014).  All KoVs share the same genome 
organisation (see Figure 3), although genes encoding 3D and VP1 show the highest 
and lowest sequence homology, respectively, between bovine KoVs, porcine KoVs 
and Aichi viruses (Cho et al. 2014).  Viral protein functions vary within the 
Picornaviridae family, with 2A working as a protease in most picornaviruses; 2B 
alters host cell membrane permeability; 2C is important for the formation of viral 
replication vesicles; 3C is a proteinase; 3D is the RNA-dependent RNA polymerase 
(RdRp); and 3A is involved in modulating the host immune response by inhibiting 
expression of host class 1 major histocompatibility complex (MHC) molecules 
(Dietz et al. 2000).  These functions in Picornaviridae are largely consistent among 
KoVs, with noted differences in 2A, VP0 and L protein functions (Reuter et al. 
2011).  The L protein is known to have no autocatalytic activity and isn’t involved in 
polyprotein cleavage, although it is expected to play a role in viral RNA replication 
and encapsidation (Sasaki et al. 2003).  In other picornaviruses, the VP0 protein is 
also cleaved into VP4 and VP2 in the later stage of capsid assembly, whereas in 







Figure 3: Genomic organisation of three recognised KoV species: Aichi virus, bovine KoV and 
porcine KoV (adapted from Reuter et al. 2011). 
 
The polyprotein is preceded by a 576-808 nucleotide 5’ untranslated region (UTR) 
which has been predicted to contain complex secondary/ tertiary stem-loop and 
cloverleaf structures that are crucial for genome replication (Sasaki et al. 2001; 
Yamashita et al. 2003).  The GC-rich nature of the first 59 nucleotides of the genome 
has made it difficult to sequence and therefore produce an infectious clone (Sasaki et 
al. 2001; Martínez-Salas et al. 2015).  The first 108 nucleotides and the secondary 
structure of this stem-loop domain are thought to be distinctive to KoVs, and also 
play an essential role in the production of virions (Sasaki et al. 2001; Oem et al. 
2014).  The Sasaki et al. study (2001) on Aichi virus indicates the folding of the 
stem-loop at the 5’ end, but not the 3’ end, is vital for viral RNA replication.  Also, 
nucleotide changes to this stem-loop structure were not found to reduce the 
efficiency of virus replication in the same study.  
In addition to the 59-terminal element found at the 5’ end, a longer element termed 
the internal ribosome entry site (IRES) is present which is involved in cap-
independent translation (Sweeney et al. 2012; Asnani et al. 2015).  The secondary 
structures of IRESs (Type IV and V) of human and bovine KoVs are unknown, 
although there are genetic differences between the three defined KoV species: 
human, bovine and porcine (Sasaki et al. 2001; Asnani et al. 2015).  The covalent 
link between the 5’ end and the viral protein g (VPg) enables the initiation of 
translation via the IRES element (Martínez-Salas et al. 2001).  Correct function of 
the IRES results in optimum replication, and determines viral pathogenesis and 




1.2.2.2  Genetic diversity 
Genetic variability among KoVs is difficult to determine, with relatively few 
sequences available that span a whole gene and even fewer complete genomes 
available.  There are partial sequences entered in GenBank cover the 3C/3D junction, 
due to the suggested benefit of using this section for classification of other 
picornaviruses.  High nucleotide and amino acid sequence homology has been 
observed within VP1 (capsid) regions of bovine (>86% and 96%, respectively) and 
porcine (>85% and 92%, respectively) KoVs (Reuter et al. 2011).  While these data 
suggest KoV infection is host-specific, cross-species infections have been detected in 
some farm animals.  Another study by Chen et al. (2013) investigating VP1 regions 
of porcine KoV isolates, found two diarrheic pigs were co-infected with multiple 
KoV strains.  Following phylogenetic analysis, sequence diversity of the isolates was 
found within the same host and between different hosts, possibly as a result of 
recombination.  Naturally, co-infection of multiples KoV strains in the same host 
could be favourable to the occurrence of these recombination events (Lau et al. 2011; 
Chen et al. 2013; Fan et al. 2013).  In the studies by Khamrin et al. (2010) and 
Okitsu et al. (2012), phylogenetic analysis of the VP1 and 3D regions of a bovine 
KoV-like strain detected in pigs suggested it may be a natural recombinant from 
porcine and bovine KoVs, as there was a higher sequence identity to the bovine U-1 
strain than any of the porcine KoVs (Yang et al. 2014).  
The pathogenic and zoonotic potential of these viruses remains uncertain.  
Antibodies to Aichi virus have not been detected in pigs or cattle and bovine U-1 
strain antibodies have not been detected in human or pig sera either (Yamashita et al. 
2003).  However, this does not rule out the possibility of other animals acting as 
carriers for the viral transmission and as a site of recombination events.  Full genome 
sequencing of KoVs detected in different species would enable more detailed 
phylogenetic studies to be carried out, with incidences and sites of recombination to 
be estimated more effectively.  
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1.2.2.3  Replication 
Currently, there are few studies exploring KoV replication or pathogenesis, with 
even less known about bovine KoV specifically.  For many picornaviruses the cell 
receptors are known, with low-density lipoproteins, extracellular matrix-binding 
proteins and integrins being just some of the cell surface molecules targeted by the 
viruses.  As with other virus families, picornaviruses follow a basic replication cycle 
(detailed in Figure 4) which provides valuable information about the role of the VPg 
and IRES structures characteristic of this family.  Cell entry mechanisms vary among 
picornaviruses.  Poliovirus, for example, interacts with its CD155 receptor resulting 
in a structural change that in turn takes part in the generation of a membrane pore. 
Through this pore it is able to enter the cell cytoplasm (Dubovi and MacLachlan, 
2010).    Following the virus uncoating, VPg at the 5’ end of the genome is removed 
by cellular enzymes allowing the ribosome to bind to viral RNA via the IRES.  The 
IRES has a cloverleaf-like structure that can bind specifically to host-cell proteins, 
stimulating the synthesis of viral protein and RNA.  Synthesis of the complementary 
strand of the replication complex (comprising of RNA templates, the virus-encoded 
RNA polymerase and several other viral and cellular proteins) is initiated at the 3’ 
terminus of the viral RNA, using the VPg as a primer.  The strand generated from 
this step then acts as a template for further synthesis of viral RNA (Whitton et al. 
2005; Dubovi and MacLachlan, 2010).  This series of events is typical of 
picornaviruses and the presence of the VPg and IRES in Figure 4, suggests their roles 




Figure 4: Summary of the picornavirus replication cycle illustrating the cell entry and involvement 
of VPg and IRES detailed in the text (from Whitton et al. 2005). 
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1.2.3  Disease association 
1.2.3.1  Kobuviruses 
A connection between KoV and diarrhoeal disease has been strongly suggested in a 
range of species, although limited pathogenesis studies have been carried out.  They 
have been associated with diarrhoeal disease in humans, pigs, goats, cats and dogs 
among others; although a definitive relationship is yet to be established (Carmona-
Vicente et al. 2013; Chung et al. 2013; Oem et al. 2014; Di Bartolo et al. 2015).  
Transmission is expected to be via the faecal-oral route, including the contamination 
of food, water and environmental surfaces, as was the case when consumption of raw 
shellfish was found to be responsible for Aichi virus-related gastroenteritis in 
humans (Le Guyader et al. 2008; Sdiri-Loulizi et al. 2010).  Mammalian KoVs have 
been detected in Europe, Asia, South America, Africa and North America (Reuter 
and Egyed, 2009; Khamrin et al. 2010; Barry et al. 2011; Sisay et al. 2013; Olarte-
Castillo et al. 2015). KoV-associated diarrhoea in young animals appears to be more 
severe than in adults, which is perhaps unsurprising as immunity plays a major role 
in protection against enteric viruses.  
A study by Reuter et al. (2010) reported porcine KoV viraemia, suggesting this KoV 
(and potentially others) are able to escape the gastrointestinal tract and move into the 
circulatory system of immunocompromised and young individuals.  If this is also 
true for bovine KoV it could provide an explanation for the contamination of cell 
culture described in Yamashita et al.’s (2003) first bovine KoV detection study, as it 
was believed the fetal bovine serum was the contaminated component.  This area of 
KoV research requires further investigation. 
1.2.3.2  Bovine kobuvirus 
One study has found bovine KoV to be endemic within the Korean diarrhoeic cattle 
population, further epidemiological studies are required to define whether it is 
endemic globally (Park et al. 2011).  The small collection of studies which used a 
sample set of both calves and adult cattle (Table 2) makes age at which immunity is 
acquired difficult to predict.  Diarrhoea in young calves (under the age of a 1 month, 
13 
 
especially) can be fatal often as a result of co-infections and highly pathogenic 
strains.  
Studies detecting bovine KoV in diarrhoeic and asymptomatic cattle are limited 
(Table 2), meaning a fair assessment of the overall impact of bovine KoV on calf 
diarrhoea is not possible at present.  Most research groups will look at only one or 
two of the groups (between age and diarrhoea status), which reduces the impact of 
the conclusions in these studies.  The Jeoung et al. study had errors in the number of 
samples used for each group, with the summary table representing the samples 
differently to that described in the text.  Another observation from these studies is the 
higher prevalence in calves compared to adult cattle.  While this may be expected 
with younger animals being more susceptible to enteric viruses, a study by Di 
Martino et al. (2012) found only a small difference between prevalence in 
asymptomatic and diarrhoeic calves (4.8% and 5.3%, respectively).  Co-infections 
with other enteric viruses, including bovine rotavirus, bovine coronavirus and bovine 
viral diarrhoea virus, in both calf and adult cattle populations have been reported 
(Jeoung et al. 2011). 
Table 2: The sample sizes and distributions between symptomatic and asymptomatic, calves and 
adult cattle. 
No. of Calves (<1 year) No. of Adult cattle (>1 year) 
Reference 
Symptomatic Asymptomatic Symptomatic Asymptomatic 
300 0 0 0 
Mauroy et al. 
2009 
61 46 
Jeoung et al. 
2011 
13 0 49 0 
Park et al. 
2011 
 
38 104 0 0 
Di Martino et 
al. 2012 
0 0 166 0 
Chang et al. 
2014 
182 0 40 0 





1.2.3.3  Kobuvirus pathogenesis 
The site of infection for bovine KoV is unknown; however, other picornaviruses 
studied in more detail (such as poliovirus and hepatitis A virus) target the M cells on 
the Peyer’s patches of surface epithelial cells in the small intestine (Takahashi et al. 
2008).  A study by Ouzilou et al. (2002) suggested a method by which poliovirus 
crosses the epithelial barrier using M cells.  The CD155-covered basolateral face of 
the enterocytes may allow poliovirus to infect the cells most efficiently, which then 
releases virions into the intestinal lumen where further amplification of poliovirus 
can occur in the gut.  Hepatitis A virus gains entry to enterocytes in a similar 
mechanism but targets the apical surface more efficiently than the bilateral surface of 
the cells (Blank et al. 2000). 
As mentioned in the previous section (1.2.3.1), porcine KoV has been detected in pig 
serum although it is not known whether this viraemia was acquired actively or 
passively (Reuter et al. 2010).  Porcine KoV has also been found to undergo 
nucleotide changes consistent with other picornaviruses, indicating good adaptation 




1.3.1  Background to Astroviruses  
The first detection and identification of AstV was by electron microscopy in 1975 
from infant diarrhoea cases on a maternity ward, and then later at a Glasgow hospital 
in the same year (Appleton and Higgins, 1975; Madeley and Cosgrove, 1975a, b).  
AstVs are small, icosahedral, non-enveloped positive sense RNA viruses, initially 
identified by the negative staining of their characteristic star-like projections on their 
virions, and thus deriving their name from the Greek word “astron” meaning star 
(Caul and Appleton, 1982; Tse et al. 2011).  The family Astroviridae is comprised of 
two genera: Mamastrovirus and Avastrovirus, which infect mammalian and avian 
hosts, respectively (Smits et al. 2010).  AstVs are generally associated with enteric 
disease in humans and has been reported as the second most common cause of viral 
gastroenteritis in young children, with rotavirus being the first (Liu et al. 2007). 
Symptoms in humans include diarrhoea and vomiting, although infections in other 
species are presumed to be subclinical in immunocompetent individuals (Moser and 
Schultz-Cherry, 2005). 
AstV-associated disease can be found away from the gastrointestinal tract, for 
example, nephritis in domestic chickens and wild birds (Todd et al. 2011; 
Honkavuori et al. 2014); hepatitis in ducks (Gough et al. 1984; Fu et al. 2009); 
shaking syndrome in mink (Blomström et al. 2010); and most recently a potential 
cause of encephalitis in humans and cattle (Quan et al. 2010; Li et al. 2013; Bouzalas 
et al. 2014; Brown et al. 2015).  At present, AstVs have been detected in numerous 
terrestrial and aquatic, domestic and wild animal species.  Some examples can be 
found in Table 3. 
Table 3: Chronological order of AstV discovery with their associated disease. 
Species Detection Associated disease Reference 
Human 1975 
Gastroenteritis in infants 
and young children 
Madeley and 
Cosgrove, 1975a 














Interstitial nephritis in 
young chicks, enteritis 
Yamaguchi et al. 
1979 
Turkey 1980 
Poult enteritis complex, 
poult enteritis mortality 
syndrome 
McNulty et al. 
1980 
Pig 1980 








Pyrexia and mild diarrhoea, 
asymptomatic 
Hoshino et al. 1981 
Red deer 1981 Diarrhoea Tzipori et al. 1981 
Duck 1984 
Acute hepatitis and 
mortality in ducklings 
Gough et al. 1984 





shaking mink syndrome 
Englund et al. 2002 
Guinea fowl 2005 Enteritis Cattoli et al. 2005 
Insectivorous 
bat 
2008 - Chu et al. 2008 
Cheetah 2009 
Lethargy and anorexia, 
watery diarrhoea 
Atkins et al. 2009 




Pup with diarrhoea, adults 
clinically healthy 
Rivera et al. 2010 
Steller sea lion 2010 
Pup without signs of 
diarrhoea 
Rivera et al. 2010 
Bottlenose 
dolphin 
2010 Clinically healthy Rivera et al. 2010 
Roe deer 2010 Diarrhoea Smits et al. 2010 
Pigeon 2011 - Zhao et al. 2011 
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Vast improvements have been made to existing techniques and the development of 
better molecular assays and investigative tools, for example enzyme-linked 
immunosorbent assay (ELISA), polymerase chain reaction (PCR), new cell lines for 
DNA cloning and high throughput sequencing (Willcocks et al. 1990; Hale, 1997).  
These methods have been used successfully to discover new AstVs in different 
species, by isolating and sequencing the virus (De Benedictis et al. 2011).  ELISA 
tests have already been applied to chicken AstV capsids to detect virus-specific 
antibodies and differentiate between maternally acquired antibodies and antibodies 
produced following acute infection (Caballero et al. 2004; Skibinska et al. 2015).  In 
cattle, ELISAs could be used to determine the prevalence and diversity of AstVs 
occurring in the British population, as well as investigating the effect of acute and 
persistent infections in calves. 
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1.3.2  Genome structure and genetic diversity 
1.3.2.1  Genome structure 
AstVs have a linear, non-segmented, positive-sense RNA genome containing three 
open reading frames (ORFs) and a poly-A tail at the 3’ end.  ORF1a encodes non-
structural polyprotein 1a and ORF1b encodes the viral RNA dependent RNA 
polymerase (RdRp), with an overlap of approximately 70nt between them.  ORF2 
encodes the viral capsid protein which has a small overlap with the RdRp of 40nt 
providing a highly conserved region compared to the remainder of the AstV 
genome (Smitts et al. 2010; Farkas et al. 2012a, b).  During the translation of 
ORF1a a -1 ribosomal frameshift occurs resulting in the translation of ORF1b.  
Unlike other viruses, this frameshift is mediated by a slippery (A)6C sequence and 
downstream structural hairpin (see Figure 5), opposed to an RNA pseudoknot as 
more commonly found, for example in coronaviruses (Jiang et al. 1993; Tse et al. 
2011; De Benedictis et al. 2011).  ORF2 encodes a polyprotein that undergoes 
proteolytic cleavage by caspase protease and processing by trypsin, with the 
purpose of promoting structural capsid protein maturation in preparation for virus 
particle release.  The role of trypsin in acquiring the mature capsid proteins VP34 
and VP27/25, forming surface spikes, have been associated with a considerable 
increase of virus infectivity (Méndez et al. 2004; van Hemert et al. 2007). 
 
 
Figure 5: Genome structure for Astroviridae family, showing the key characteristic features for 
replication (modified from de Benedictis et al. 2011) 
The proteolytic maturation of the virus particles described causes consequent 
conformational changes in the AstV capsid, perhaps most importantly in the spike 
domains.  High-resolution crystal structures of mammalian and avian AstV capsid 
spike domains have shown differences between potential host receptors, requiring 
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further investigation into species specificity and host entry (Dong et al. 2011; 
DuBois et al. 2012, 2013).  AstV virion structure and capsid spikes have a strong 
similarity to those of Hepatitis E virus (HEV) (see Figure 6), indicating a closer 
evolutionary relationship than previously thought.  This information could provide 
vital clues to unknown areas of AstV research such as pathogenesis and innate 





Figure 6: Comparison of human astrovirus (HAstV) and HEV structures.  The tertiary structure of 
immature HAstV (a) is very similar to that of HEV (b) (modified from DuBois et al. 2013). 
 
Spike domains of human and avian AstVs have some fundamental differences in 
their structures.  The b-strands being solely responsible for the bowl-shaped dimeric 
spike of HAstVs contrasts to the additional helices found in spike domains forming 
the heart-shaped structure of avian AstVs (see Figure 7).  Studies into structural 
homology have found the HEV spike domain to be more closely related to the avian 
astrovirus spike domain to that of HAstV.  The low sequence homologies and 
structural conservation between human and avian AstVs suggests they may have 
substantial differences in host entry and immune cell interactions (Dong et al. 2011; 

















Figure 7: Comparison of the human and avian AstV spike structures.  Dimeric structure of the 
HAstV 8 capsid spike (a) and of the turkey AstV 2 (TAstV-2) spike (b) shown as cartoon (top) and 
surface (bottom) representation.  In the cartoon representations, one protomer has a blue-to-red 
colouration from N- to C- termini whereas the other protomer is coloured grey.  In the surface 
representations, one protomer is coloured red and the other blue (modified from DuBois et al. 
2012, 2013). 
AstVs have a viral genome-linked protein (VPg) covalently linked to the 5’ end of 
the genome by a phosphodiester bond.  In picornaviruses, VPgs have numerous 
functions including playing vital roles in genome replication, viral protein synthesis 
and potentially genome encapsidation (Goodfellow, 2011).  Several studies have 
suggested the probability of a VPg on the HAstV genome, which would play a 
crucial role in viral infectivity as found in other virus families.  Proteinase K 
treatment removes this VPg from the 5’ end of the genome, therefore preventing 
protein synthesis and replication of the virus.  This action eliminates the recovery of 
infectious viruses post transfection, making these viruses safer during infection 
studies without the risk of infection to researchers (Al-Muitairy et al. 2005; 
Velázquez-Moctezuma et al. 2012; Fuentes et al. 2012).  
1.3.2.2  Host range and capsid variability  
Genetic variability, as common with most RNA viruses, has been described for the 
vast majority of mammalian and avian AstV species including porcine AstVs (Lee et 
al. 2015; Luo et al. 2011), bovine AstVs (Tse et al. 2011; Candido et al. 2015; Sharp 
et al. 2015), bat AstVs (Chu et al. 2008; Drexler et al. 2011), turkey AstVs (Cattoli 
et al. 2007; Strain et al. 2008) and chicken AstVs (Todd et al. 2009; Pantin-
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Jackwood et al. 2011), to name a few (Figure 8).  Studies on AstV capsid structure 
have suggested a greater host immune and environmental pressure resulting in 
synonymous or non-synonymous nucleotide substitutions, with receptors that interact 
with immune cells most susceptible to these changes.  Recombination events are 
known to occur across the mam- and avastrovirus species, with at least one expected 
during the evolution of bovine astrovirus and roe deer AstVs (Tse et al. 2011) and 
evidence of recombinations in two separate studies on turkey AstVs in the USA 
(Pantin-Jackwood et al. 2006; Strain et al. 2008).  Oem and An’s study (2014) 
provides evidence for probable recombination in ORF2 of bovine faecal samples. 
Naturally, the ability of AstVs to undergo recombination in a relatively short period 
of time has raised the important question of whether these animal AstVs could 
recombine with HAstV, thus facilitating zoonotic transmission and the emergence of 
novel viruses into the animal and human populations.  Current evidence for this is 
limited with just one study by Rivera and colleagues (2010) reporting the potential 
interspecies transmission between a Californian sea lion and its carer, and another by 
Ulloa and Gutierrez (2010) describing a possible recombination event between a 
porcine AstV and HAstV3.  Lukashov and Goudsmit’s study in 2002 suggests that a 
least two cross-species transmissions involving pigs, cats and humans may have 
taken place in the virus’ history, potentially through the use of intermediate hosts.  
The recent association of encephalitis with neuro-AstV in humans (Quan et al. 2010) 
and cattle (Li et al. in 2013), has also attracted interest to the potential of 
recombination events leading to zoonotic transmission and even causing 
inflammation in the brain.  
As expected, ORF2 shows the most diversity among different host species as this 
enables the virus to interact with specific host cell receptors and successfully 
replicate.  This equates to a single host species being susceptible to infection by 
divergent AstVs, for example the classic human genotypes (1-8), VA and MLB 
strains of HAstV do not cluster to form a monophyletic group (Strain et al. 2008; Tse 
et al. 2011).  Conversely, some studies have suggested that some HAstVs have 
multiple hosts.  The Kapoor et al. (2009) study reports the presence of human-mink-
ovine AstVs or ‘HMOAstVs’ from human stools, which are phylogenetically distinct 
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to other AstVs previously found.  Another example is from Finkbeiner and 
associates’ (2009) work where they noted the close genetic relationship between 
HAstVs and circulating rat AstVs in Hong Kong.  These phylogenetic studies 
suggest the ability of these viruses to infect multiple species, although this hasn’t yet 
been explicitly studied.  While HAstV genotypes have been found to differ in 
virulence (Caballero et al. 2003; Holtz et al. 2011), the pathogenic potential of 
different phylogenetic groupings have not been collectively studied to the same 
extent in non-human mammals. 
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 238684374|California sea lion astrovirus
 484400094|Fox astrovirus
 261597214|HMO astrovirus B
 261597217|HMO astrovirus C
 748302259|VA1/HMO-C astrovirus
 225380928|Bat astrovirus Tm/Guangxi/LD54/2007
 238684384|Bottlenose dolphin astrovirus
 28867239|Mink astrovirus
0.2  
Figure 8: Neighbour-joining tree comparing the diversity of mammalian AstVs, based on full 
genome sequences (including GenBank numbers).   
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1.3.2.3  Replication 
AstV replication has been most extensively studied for human AstVs (summarised in 
Figure 9), although the mechanism is expected to be very similar, if not the same, for 
other mammalian AstVs.  The virus entry mechanism adopted by HAstV is clathrin-
mediated endocytosis, although the method for releasing the genome from the virus 
particle into the cytoplasm for translation, and the site where this occurs, remains 
unknown (Méndez et al. 2012).  The extra-cellular signal-regulated (ERK1/2) 
pathway is activated by an interaction between HAstV and the host cell, and is 
thought to be required to establish productive infection.  Following uncoating of 
genomic RNA, it has been suggested the VPg recruits the cap binding protein eIF4E 
to initiate translation, as observed in caliciviruses.  Non-structural proteins are 
translated as two polyproteins (nsp1a and nsp1ab), of which nsp1ab requires a 
translational fusion of ORF1a and ORF1b that produces a -1 frameshift to be 
synthesised (Lewis and Matsui, 1996).  Individual non-structural proteins are 
consequently produced by the cleavage of nsp1a and nsp1ab by viral serine protease 
(Gibson et al. 1998).  The non-structural protein, nsp1a has been found to be 
essential for virus replication (along with the viral polymerase) and has been 
suggested to produce the VPg characteristic of AstVs (Al-Mutairy et al. 2005; Guix 
et al. 2005; Fuentes et al. 2011). 
In addition to the VP34 and VP27/25 spike proteins, other proteins such as VP90 and 
VP70 are also synthesised from the ORF2.  The 90-kDa protein VP90 assembles into 
virus particles before being cleaved by caspases to produce the 70-kDa VP70 protein 
through several intermediate stages.  VP90 and VP70 have been associated with the 
exit of virus particles from the cell (Méndez et al. 2002).  In order for the VP70 
virions to fully activate their infectivity they require treatment with trypsin, which 
cleaves the VP70 into three smaller products and improves virus infectivity up to 
105-fold.  The mechanism for this cleavage is, however, unknown (Lee and Kurtz, 
1981; Bass and Qiu, 2000). 
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The release method of viral particles from the infected cell is uncertain, although it 
has been found that the capsid assembles in the absence of viral RNA, carried out in 
association with cellular membranes and requires the action of cellular caspases 
during the final stages of assembly (Méndez et al. 2012). 
 
 
Figure 9: The replication mechanism for HAstVs (Méndez et al. 2012). 
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1.3.3  Disease association 
Since the first observations of AstV-associated outbreaks of gastroenteritis in infants 
in 1975, AstVs have been strongly connected to viral gastrointestinal disease in 
infants, the elderly and immunocompromised people (Noel and Cubitt, 1994; 
Maldonado et al. 1998; Koci et al. 2003; Meyer et al. 2015).  Furthermore other 
studies have reported a similar trend with the AstVs detected in the diarrhoea of 
young animals.  Recent studies have found a low prevalence in adult cattle 
populations compared to calf populations (Tse et al. 2011; Sharp et al. 2015), which 
suggests there may be acquired immunity after initial infection (Bosch et al. 2010).  
1.3.3.1  Bovine astrovirus 
Association between bovine AstV and calf diarrhoea has been disputed since its 
initial discovery in the 1980s, with new technological developments providing 
evidence for its involvement in calf diarrhoea and its role as a co-factor of mixed 
infections.  The series of studies by Woode and colleagues often found the presence 
of rotavirus particles in faecal samples or rotavirus antibodies in serum whilst testing 
for AstV infection (Woode and Bridger, 1978; Woode et al. 1984; Woode et al. 
1985).  Initial studies suggested AstV was avirulent in calves following the absence 
of clinical signs in infected gnotobiotic calves.  Later investigation discovered 
cytopathological changes to the M cells of the dome epithelium covering the Peyer’s 
patches when infected with either AstV and rotavirus or AstV and Breda virus 2 
(Woode et al. 1984).  However, rotavirus and AstV infected calves were found to 
produce a strong rotavirus serological response similar to that produced by AstV 
negative, rotavirus positive calves.  This suggested rotavirus may be the primary 
pathogen but the effect of AstV on reducing or enhancing the function of Peyers’ 
patches remained unknown.  Calves infected with AstV and rotavirus produced 
severe diarrhoea and excretion of both viruses, compared with the yellow soft faeces 
of calves infected with AstV alone (Woode et al. 1984). The Woode et al. 1985 
study found AstV could be shed in faeces in this instance for 25 days post-infection.  
It was also concluded from these studies that more mixed infection studies with other 
enteric viruses and cryptospiridia would be beneficial to establish the role of 
different pathogens in calf diarrhoea. 
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Later studies of AstV in European roe deer and cattle (in 2010 and 2011, 
respectively) revisited the diarrhoea association with new data showing the presence 
of AstV in a deer population with gastroenteritis, which was genetically distinct from 
the bovine AstVs previously described by (Smits et al. 2010; Tse et al. 2011).  This 
diversity was believed to be as a result of co-infections with multiple virus strains in 
one individual potentially causing recombination events, as found in a similar study 
looking at porcine AstV diversity (Luo et al. 2011).  A new study by Sharp et al. 
(2015) found no association between the presence of AstV and calf diarrhoea, but did 
find a strong link between the presence of AstV and rotavirus Group A.  Following 
previous studies on the various connections between enteric viruses and calf 
diarrhoea (Cho et al. 2013; Coura et al. 2015), this study helps to clarify the 
association of AstV with diarrhoea, and suggests the contribution of rotavirus to be 
more substantial. 
1.3.3.2  Neuro astrovirus 
Recently, several cases of human AstV infection have been reportedly associated 
with encephalitis and other neurological symptoms.  In a study by Quan et al. (2010), 
AstV was exclusively identified in the CNS of a 15 year old immunocompromised 
male with X-linked agammaglobulinemia showing signs of encephalitis.  Another 
study by Naccache et al. (2015) used next-generation sequencing (NGS) to identify 
an AstV, of the VA/HMO clade (see Figure 8), as the causative pathogen of a fatal 
progressive encephalitis in an adult male following a bone marrow transplant.  
Furthermore, the Brown et al. (2015) investigation into the encephalitis after a stem 
cell transplant in an infant, found a HAstV-VA1/HMO to be responsible, also by 
NGS.  The VA1/HMO clade are human-mink-ovine-like AstVs which are highly 
divergent compared to the enteric AstVs and have been associated with these 
encephalitis cases in humans (Finkbeiner et al. 2009).  
An AstV associated with neurological disease was discovered on Danish mink farms 
in 2000 and 2003.  Upon sequencing of the causative pathogen, its identification as 
an AstV has provided a whole new area of interest for AstV research (Mittelholzer et 
al. 2003a, b; Blomström et al. 2010).  The clinical signs included shaking, staggering 
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gait and lesions characteristic of nonsuppurative encephalomyelitis identified post-
mortem (Blomström et al. 2010).  Congenital tremor, another disease of the central 
nervous system (CNS) is linked to detection of AstV in the cerebrum, brain stem and 
cerebellum in newborn piglets.  However, these porcine “neuro AstVs” have been 
detected in healthy piglets as well as those with congenital tremor, casting doubt on 
their aetiological role (Blomström et al. 2014).  
1.3.3.3  Bovine neuro astrovirus 
Bovine neurotropic AstV (BoAstV-NeuroS1) was first recorded in a study by Li et 
al. in 2013, in which a brain sample from a calf with encephalomyelitis and 
ganglioneuritis was analysed by viral metagenomics.  Another study in 2014 also 
reported the presence of neurotropic AstV (BoAstV-CH13) in 5/22 brain samples 
from cattle with nonsuppurative encephalitis, phylogenetically closely related to 
ovine AstV (enteric) and other AstVs isolated from animal and human encephalitis 
cases (Bouzalas et al. 2014; Oem and An, 2014).  While cattle with neurological 
signs are attentively screened, particularly since the 1996 BSE outbreak in the UK, 
the causative pathogen often remains unknown (Lloyd et al. 2006; Li et al. 2013).  
AstVs are not part of this routine screen, although recent findings and the potential 
for zoonotic transmission via the faecal-oral route may bring about the use of next-
generation sequencing and in situ hybridization for diagnosis (Bouzalas et al. 2014). 
While neurotropic AstVs show a low phylogenetic similarity to enteric AstVs, they 
are closely related to the lineage of AstVs also found in association with neurological 
disease in mink and cattle (Brown et al. 2015).  Transmission of this AstV group is 
under speculation, with intravenous immunoglobulin, close residence to mink and 
cattle farms and the faecal-oral route being suggested (Quan et al. 2010; Brown et al. 
2015).  Similar to enteric strains, these AstVs have so far been found in 
immunocompromised adults and children (often following tissue transplants and 
blood transfusions) therefore establishing transmission routes is vital to ensuring the 





1.3.3.4  Astrovirus transmission 
Enteric AstVs are transmitted via the faecal-oral route, as common with other viruses 
affecting the gastrointestinal tract (Méndez and Arias, 2007).  Replication of these 
viruses within the host results in large quantities of virus being excreted for up to 5 
days post-infection in cattle, and can therefore spread into the communal 
environment (Woode et al. 1984; Prevost et al. 2015).  The ability of AstVs to 
remain stable at cold temperatures means AstV outbreaks are more likely during late 
autumn through to early spring (Bosch et al. 2010).  
Husbandry can have a considerable impact with segregating diarrhoeic animals, 
frequently changing bedding and regularly cleaning out pens thus reducing 
transmission.  The calving pattern of cattle means they can calf all year round, 
therefore choosing a calving period between late spring and early autumn would be 
beneficial to reducing risk of viral gastroenteritis.  Contamination of surfaces and 
other fomites has been studied for HAstVs and have been found to act as alternative 
transmission routes (Abad et al. 2001; Gallimore et al. 2005).  Chloro-derivitives, 
such as chlorine, and high concentration ethanol (≥ 90%) have been found to 
inactivate AstVs in water and on surfaces and are common components of strong 
disinfectants (Kurtz et al. 1980; Superti et al. 1990; Espinosa et al. 2008).  
1.3.3.5  Astrovirus pathogenesis 
Upon the first detection of AstV in calves in the 1970s, pathogenesis studies took 
place to investigate the infection mechanism in animals inoculated with AstV.  These 
studies infected gnotobiotic and conventionally reared calves with AstV (without the 
presence of other gut pathogens) and found lesions in the M cells of the Peyers 
patches on post mortem (Woode et al. 1984; Woode et al. 1985).  The lesions were 
suggested to have a damaging effect on the gut immune response, thus making them 
more susceptible to infection from other gut pathogens (Woode et al. 1985).  Since 
these initial investigations the mechanism of AstV -induced diarrhoea remains 
unknown, however, there has been speculation of different mechanisms such as 
destruction of the intestinal epithelia; modulation of ions channels; or induction of 
intestinal epithelial barrier permeability (Meliopoulas and Schultz-Cherry, 2011).  In 
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turkeys, where AstV is known to cause enteritis, increased intestinal barrier 
permeability has been found to be the primary factor responsible for infection (Moser 
et al. 2007).  In the Moser et al. study, an increase in permeability correlated with the 
disruption of tight-junction proteins, further increasing when monolayers were 
treated with UV-inactivated virus or purified recombinant HAstV capsid.  This 
suggests AstV-induced permeability occurs independently of viral replication and is 
controlled by the capsid protein, a characteristic thought to be unique for AstVs. 
1.3.3.6  Site of infection   
If AstV infection does occur in cattle the mechanism is unknown, although multiple 
cellular attachments or receptor molecules are believed to be involved (Méndez et al. 
2012).  For neurological bovine AstVs, viral RNA has been detected throughout the 
brain and nervous system including the neurons in the spinal cord, brainstem and 
cerebellum (Li et al. 2013).  When examined further, lesions were of widespread 
neuronal necrosis, microgliosis (accumulation of microglial cells) with damage also 
found to the cerebellum and brainstem (Li et al. 2013; Bouzalas et al. 2014).  This 
neuropathology is consistent with the AstV-related encephalitis in human cases 




1.4  Background to study 
A family-owned farm in South West Scotland, Farm M, experienced two outbreaks 
of fatal diarrhoeal disease in newborn calves between spring 2012 and winter 
2012/13, causing serious concern for the calves’ welfare and distress for the farmer.  
Following the routine screening for common enteric pathogens with no pathogenic 
agent consistently detected in the diarrhoeic calves, the samples were screened for 
novel pathogens at the Roslin Institute.  Samples from diarrhoeic and non-diarrhoeic 
calves from 6 farms in the Dumfries and Ayrshire region were found to be negative 
for parvoviruses and bocaviruses, while perhaps unsurprisingly; AstV, rotavirus and 
KoV were detected across all the farms sampled.  AstV was not found to be 








1.5  Aims of the project 
Following the recent detection of both viruses in samples from diarrhoeic and 
healthy calves in south west Scotland, I will be using the samples available to 
explore these objectives: 
a) Sequence the full bovine KoV genome from a diarrhoeic calf 
b) Assemble the bovine KoV genome for future virus challenge studies. 
c) Sequence and prepare bovine AstV capsids for use in baculovirus expression 
system, to develop an ELISA for detection of AstV in serum. 
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2.  Materials and methods 
2.1 Sample selection 
The samples were provided by SAC Consulting: Veterinary Services during an 
investigation of calf diarrhoea across 36 different farms in South West Scotland 
between November 2012 and January 2013.  On collection, the samples were 
suspended in 1ml RNAlater (Ambion) and stored at -20°C until extraction.  For this 
study, 7 calf samples from Farm M (6 diarrhoeic, 1 healthy) and 8 diarrhoeic calf 
samples from Dumfries and Ayrshire which had tested positive for AstV and/or KoV 
were selected (Table 4). 





Date received (by 
Roslin Institute) 
Health status Calf 
number 
KoV Dumfries/ Ayr Dec 2012 - Jan 2013 Diarrhoeic  1  
KoV Dumfries/ Ayr Dec 2012 - Jan 2013 Diarrhoeic  2 
KoV Dumfries/ Ayr Dec 2012 - Jan 2013 Diarrhoeic  3 
KoV Dumfries/ Ayr Dec 2012 - Jan 2013 Diarrhoeic  4 
KoV Dumfries/ Ayr Dec 2012 - Jan 2013 Diarrhoeic  5 
KoV Dumfries/ Ayr Dec 2012 - Jan 2013 Diarrhoeic  6 
KoV Dumfries/ Ayr Dec 2012 - Jan 2013 Diarrhoeic  7  
KoV Dumfries/ Ayr Dec 2012 - Jan 2013 Diarrhoeic  8  
AstV Farm M Nov - Dec 2012 Healthy HC 8 
AstV Farm M Nov 2012 Diarrhoeic  Calf 2 
AstV Farm M Nov 2012 Diarrhoeic  Calf 3 
AstV Farm M Nov 2012 Diarrhoeic  Calf 4 
AstV Farm M Nov - Dec 2012 Diarrhoeic  Case 2 
AstV Farm M Nov - Dec 2012 Diarrhoeic  Case 3 





2.2 RNA Extraction 
In preparation for extraction, samples were thawed and pelleted by centrifugation at 
13,000xg for 5 minutes allowing the formed pellet of waste debris material to then be 
removed.  The RNeasy Mini Kit (Qiagen) was used to extract nucleic acids from 
120µl of faecal supernatants using wash buffers RLT and RPE before elution in 30µl 
nuclease-free water. 
2.3 Reverse Transcription  
For the generation of cDNA, 11µl of RNA was added to a tube containing 1µl of 
random hexamer primers and 1µl nuclease-free water, before incubation at 65°C for 
5 minutes.  The product is then added to a mixture containing 4µl of 5X First-Strand 
Buffer; 1µl of 0.1M DTT; 1µl of RNaseOUT™ Recombinant RNase Inhibitor and 
1µl of SuperScript™ III reverse transcriptase (Life Technologies), and incubated at 
25°C for 5 minutes.  Finally, the mixture was incubated for 30 minutes at 50°C and 
then 70°C for 15 minutes to inactivate the reaction.   
2.4 PCR 
During this project several DNA polymerases, reagent quantities and conditions were 
used to optimise PCR for the desired regions of the virus genomes.  Details on the 
final optimal reagent quantities and conditions can be found in the results section. 
Below are the standard reagents and reaction conditions used before any 
optimisation.  
GoTaq® (Promega) 
For a 50µl reaction, it would contain the following: 10µl of 5x GoTaq® buffer, 1 µl 
of dNTPs, 1µl of 10µM forward primer, 1µl of 10µM reverse primer, 0.25µl of 
GoTaq® DNA polymerase, 2µl of cDNA template (5µl for 2
nd
 round) and nuclease-
free water up to a final quantity of 50µl.  The conditions advised are: 94°C for 1 
minute, 30 cycles of [94°C for 30 seconds, 42-65°C for 30 seconds, 68°C for 1 
minute/Kb], 68°C for 5 minutes and hold at 4°C. 
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LongAmp® (New England Biolabs) 
The LongAmp® 25µl reaction contains 5 µl of 5x LongAmp® Taq buffer, 0.75µl of 
10mM dNTPs, 1µl of 10µM forward primer, 1µl of 10µM reverse primer, 1µl 
LongAmp® Taq DNA polymerase, 1µl of template cDNA and nuclease-free water to 
the total of 25µl.  The conditions described are: 94°C for 1 minute, 35 cycles of 
[94°C for 30 seconds, 45-65°C for 1 minute, 65°C for 1 minute/kb], 65°C for 10 
minutes and hold at 10°C. 
SequalPrep™ Long (Life Technologies) 
The SequalPrep™ Long reaction contains: 2µl of SequalPrep™ 10X buffer, 0.9µl of 
DMSO, 1µl of SequalPrep™ 10x Enhancer A, 0.36µl of SequalPrep™ Long 
Polymerase, 1µl of 10µM forward primer, 1µl of 10µM reverse primer, 1µl cDNA 
template and nuclease-free water up to 18µl.  The conditions are the following: 94°C 
for 2 minutes, 9 cycles of [94°C for 10 seconds, primer Tm-5°C for 30 seconds, 68°C 
for 1 minute/kb], 29 cycles of [94°C for 10 seconds, primer Tm-5°C for 30 seconds, 
68°C for 1 minute/Kb (+20 seconds/cycle)] and a final extension at 72°C for 5 
minutes. 
Herculase II Fusion (Agilent) 
For a PCR target of 1-10Kb the following reaction is recommended: 10µl of 5x 
Herculase II buffer, 5µl of dNTPs, 1µl of 10µM forward primer, 1µl of 10µM 
reverse primer, 1µl of Herculase II fusion DNA polymerase, 1µl of cDNA template 
and nuclease-free water up to a total volume of 50µl.  The conditions are: 94°C for 2 
minutes, 35 cycles of [94°C for 18 seconds, primer Tm-5°C for 21 seconds, 72°C for 
60 seconds/Kb] and a final extension at 72°C for 5 minutes. 
Phusion® High-Fidelity (New England Biolabs) 
For a 50μl reaction the following is recommended: 10µl of 5X Phusion® HF (or GC) 
Buffer, 1µl of 10mM dNTPs, 2.5µl of 10µM forward primer, 2.5µl of 10µM reverse 
primer, 0.5µl Phusion® DNA polymerase, 2µl of DNA template and nuclease-free 
water to the total of 50µl.  The conditions are: 98°C for 30 seconds, 30 cycles of 
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[98°C for 8 seconds, 45-72°C for 25 seconds, 72°C for 1 minute per kb] and a final 
extension of 10 minutes at 72°C.  
AccuPrime™ (Invitrogen) 
A 50μl reaction contains the following: 5μl 10X AccuPrime™ PCR buffer I, 1µl of 
10µM forward primer, 1µl of 10µM reverse primer, 0.2μl of AccuPrime™ Taq high 
Fidelity, 2µl of DNA template and nuclease-free water to the total volume of 50μl.  
The conditions are: 94°C for 2 minutes and 35 cycles of [94°C for 18 seconds, 52-
64°C for 21 seconds, 72°C for 1 minute per kb] and a final extension of 5 minutes at 
72°C. 
2.5 Electrophoresis and gel extraction 
PCR products were visualised on 2% agarose gels by electrophoresis.  The gels were 
made using LE agarose powder (Promega) and TAE buffer, adding the DNA stain 
SYBERSAFE as a safer alternative to ethidium bromide.  The products were loaded 
alongside GeneRuler DNA Ladder Mix (Thermo Scientific) and viewed under UV 
light using a UV-transillumination advanced imaging system.  Where amplicons of 
appropriate size were seen with other products present, they were extracted and 
purified using QIAquick Gel Extraction kit (Qiagen) according to manufacturer’s 
instructions.  When just one amplicon was produced of the appropriate size, the PCR 
product was used directly for cloning and sequencing. 
2.6 Sequencing 
2.6.1 BigDye sequencing  
Single amplicons from PCR reactions, on plasmid DNA were sequenced using the 
BigDye V 3.0 kit (Applied Biosystems™) and the same primers used to initially 
generate the PCR product.  The sequence reaction contained 7.9µl nuclease-free 
water, 2µl 5x BigDye Buffer, 0.6µl primer (either forward or reverse primer used), 
0.5µl BigDye and 1µl PCR product (1 in 10 dilution).  The reaction took place under 
the following conditions: 20 cycles of 30 seconds at 96°C, 20 seconds at 50°C and 4 
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minutes at 60°C.  On completion reactions were sent to the Edinburgh Genomics 
Sequencing Service. 
For amplicons where end sequencing was insufficient for complete coverage, 
specific primers were designed (see Table 5) by primer walking.  These primers were 
designed to contain a high GC content (between 50 and 65%) and annealing 
temperatures of <60°C. 
Table 5: Primers used for internal sequencing of DNA plasmids (in addition to primers used for 
PCR). 




1495AS Antisense 21 RACCGTTAGCACCGAGATCGG 
1887s Sense 20 GGCTCCTGGACACTTTCGAG 
2111s Sense 22 GTGCAGGCGTATCCAGACTGCC 
2878s Sense 21 GCCTGGTCATATGCTATTCAC 
2878s Sense 21 GCCTGGTCATATGCTATTCAC 
2908AS Antisense 26 CAGGGTGTGYCAYATCCAYGGCGCRT 
2883s Sense 26 TRCGCGGYACCTAYACYGTGTGGGAC 
4082s Sense 24 GCCCARTGGRTGTASGTCATGCGC 
4199s Sense 21 GGTCTACCRAGARGTAGAACC 
4720s Sense 20 GGCTTCGCACTACTTCACCG 
480s Sense 22 CCAGTGTGCGCAACAGTATGTT 
4898AS Antisense 20 TCTCTCGGTGAAGTAGTGCG 
4983s Sense 23 ATGGCAGCAGCCTCAGCCTCCTC 
4997s Sense 24 ACACCGTCGTTGAAATCACGCACG 
7093-7112s Sense 20 CCTACCGCACCTGTACTTGG 
7154-7175s Sense  22 GCGAGTAACAAGTAACTTCTCC 
7581-7562AS Antisense 20 GGTAGGCTTGCATGTACTCG 
7628-7609AS Antisense 20 CCAGTGGAGGTCTGGGTTGC 
7918s Sense 23 GGAGTTCGCTACCAAACAAGGCC 
8199AS Antisense 22 CAGCCACATGACGGACTGCTCG 
8199as Antisense 22 CAGCCACATGACGGACTGCTCG 
8270s Sense 22 GCGACCACGCTTGCACAAGCAC 
Calf 1 6916s Sense 19 GCGTGATGCTCGTCTCGAG 
Calf 1 6917s Sense 20 CGAGCAGAGCTCGGACCTTG  
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Calf 1 6941s Sense 20 GACCTACTGGTTGAGAAGGA  
Calf 1 6978s Sense 20 GCTTAAGGGCGCCGGCGGTA  
Calf 1 7978s Sense 20 CCACGCTAGGAGGTTAGGTG 
Calf 7 1150s Sense 22 CTGGTGTGACATCCTTGACGAG 
Calf 7 1589s Sense 20 CTTGGACGACGAAGCTTCCG 
Calf 7 7509AS Antisense 20 CTGACTCGTGTGGTTGAGGC 
Calf 7 7512AS Antisense 20 CAGCCTCAACCACACGAGTC  
Calf 8 3392s Sense 20 CCACTGTGGGACGGAGAGGA 
Calf 8 4720s Sense 20 GGCTTCGCACTACTTCACCG 
Healthy calf 8 
4666s 
Sense 20 CGCATGGCACGCGCTGAAAC 
BAstV 
4334s Sense 20 GGCGGGACCATCTAAATCCG 
4712s Sense 20 GGATGGTGACAGACACGGTC 
4898s Sense 24 CATCCACCTCCTTTCAGGAAGTTG 
5590AS Antisense 22 TGAAGCTATGCTCAGTCTCAGC 
BovAstCapsid 
1-2S 
Sense 23 GTGTATTCATCTATAAATGACGC 
BovAstCapsid 
2-2S 
Sense 23 GTGTATTCATCTATAAATGACGC 
BovAstCapsid 
3-2S 
Sense 23 CATCAATAAATGATGCACGTGCC 
BovAstCapsid 
4-2S 
Sense 27 CTTTGATGTGTTCCCCTCCATGTCAGA 
 
2.6.2  Sequence Analysis 
Returned sequences were analysed using NCBI BLAST to check nucleotide identity 
to other sequences of the virus in the database, with high similarity sequences 
imported into an alignment using the SSE program (Peter Simmonds, 2013).  This 
alignment program enables the alignment, annotation, classification and direct 
analysis of sequences using a number of built-in bioinformatic programs.  For this 
project the program was mainly used to import sequences from different resources 
for designing primers; assembling large fragments from single sequences and 
carrying out analysis between both groups and individual sequences.  NEB Cutter 
V2.0 was used to identify restriction sites in sequences to enable the selection of 
restriction enzymes for assembly and cloning into different vectors.  MEGA6 was 
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used to align imported sequences from GenBank and those generated from this study 
to carry out phylogenetic analysis.   
2.7 Molecular Cloning 
2.7.1  Ligation 
For PCR products produced using GoTaq® (Promega), LongAmp® (New England 
BioLabs),  SequalPrep™Long (Thermo Scientific) or AccuPrime™ (New England 
Biolabs) DNA polymerases, the pGEM®-T Easy Vector kit (Promega) was used for 
ligation and transformation.  These ligation reactions contained 1µl nuclease-free 
water, 5µl 2x ligation buffer, 1µl pGEM®-T Easy Vector, 1µl T4 DNA ligase and 
2µl PCR product.  They were incubated at 4°C for between 24 and 72 hours. PCR 
products generated using Herculase II Fusion (Agilent) were ligated and transformed 
using the Zero Blunt® TOPO® PCR cloning kit.  The ligation reaction comprised of 
2µl blunt-ended PCR product, 0.5µl salt solution and 0.5µl pCR®Blunt II-TOPO® 
vector, which was then incubated for 10 minutes at room temperature. 
For the ligation of DNA fragments in the FastBac vector, the reagents included were: 
7μl of purified product, 1μl of FastBac vector, 1μl of 10x T4 ligase buffer and 1μl T4 
ligase.  This reaction was then incubated at 16°C overnight, to provide sufficient 
time for ligation of the fragment into the vector. 
2.7.2  Transformation 
Transformation of both the pGEM®-T Easy Vector ligation and pCR®Blunt II-
TOPO® Vector were carried out by adding 2µl of the ligation reaction to 50µl 
thawed DH5α™ Competent Cells (Invitrogen) on ice.  Following an incubation of 20 
minutes, the reaction was heat-shocked in a water bath at 42°C for 30 seconds before 
being returned to the ice to cool for 2 minutes.  SOB medium was then added to the 
tube to a total volume of 1000µl, before incubation at 37°C for 1 hour with 
horizontal shaking.  The cells were plated out with 100µl or 200µl per plate and 
incubated at 37°C overnight.  The LB plates for the pGEM®-T Easy Vector ligations 
contained ampicillin (100µg/ml), IPTG (100mM) and X-Gal (50mg/ml), while 
pCR®Blunt II-TOPO® Vector ligation plates contained kanamycin (30µg/ml). 
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2.7.3  Colony PCR 
A colony PCR is used to check the fragment has been ligated successfully into the 
plasmid.  M13 primer sites are located either side of the insert region in both 
pGEM®-T Easy pCR®Blunt II-TOPO® vectors.  For the ampicillin plates only 
white (as opposed to blue) colonies were selected for PCR, while all colonies on the 
kanamycin plates were available for PCR.  Up to 8 colonies were picked from each 
transformation and added to 15µl LB in PCR strip tubes for storage at 4°C.  Specific 
primers for the M13F (5’-GTA AAA CGA CGG CCA G-3’) and M13R (5’-CAG 
GAA ACA GCT ATG AC-3’) sites located either side of the cloning site of 
pGEM®-T Easy or pCR®Blunt II-TOPO® vectors were used for PCR.  The PCR 
master mix included 18.6µl nuclease-free water, 0.5µl dNTPs, 5µl 5x GoTaq® 
Buffer, 0.15µl M13F, 0.15µl M13R, 0.1µl GoTaq®, and 1µl of colony LB solution.  
Conditions for the PCR were 95°C for 2 minutes, 30 cycles of [95°C for 30 seconds; 
50°C for 30 seconds and 72°C for 3 minutes (1kb= 1 minute)] and a final extension 
of 72°C for 5 minutes.  The PCR products were visualised on a 2% agarose gel, 
extracted and purified as previously described (2.5).  
2.7.4  Plasmid DNA extraction 
Extraction of plasmid DNA from the bacterial cells was completed using QIAprep 
Miniprep kit (Qiagen) according to manufacturer’s instructions.  Briefly, 1µl of 
colony LB solution (stored at 4°C) was added to 5ml of LB and incubated at 37°C in 
a shaking incubator for 16 hours.  The culture was pelleted by centrifugation at 
4000rpm for 8 minutes and the supernatant removed, before being re-suspended in 
Buffer P1.  This solution was then transferred to a 1.5ml tube where Buffer P2 was 
added and mixed by inversion, followed by Buffer N3 in the same way.  Particulate 
material was pelleted by centrifugation for 10 minutes and the supernatant carefully 
extracted and applied to QIAprep spin columns.  Following centrifugation and 
washing with Buffers PB and PB, DNA was eluted using 10µl Buffer EB and 
collected in a sterile 1.5ml tube.  
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2.8  Rapid amplification of 5’ and 3’ ends 
The GeneRacer™ Kit (Invitrogen) was used to amplify the 5’ and 3’ ends of the 
KoV genome, according to manufacturer’s instructions.  The method involved the 
generation of cDNA with an attached GeneRacer™ dT oligo which was 
consequently used for PCR with the 5’ GeneRacer™ primer and a pre-designed 
sequence-specific antisense primer.  To produce the cDNA, total RNA extracted 
from the sample undergoes stages of dephosphorylation; decapping of mRNA; 
ligation of the GeneRacer™ oligo; and reverse transcription with phenol extractions 
and ethanol precipitations at each stage.  The kit is designed to produce a single 
product which can be visualised and extracted from an agarose gel before cloning 
into pCR® 4-TOPO or pCR® 4Blunt-TOPO. 
2.9 Restriction digest and ligation into FastBac vector 
Restriction digests contained the following reagents to total a 20μl reaction: 2μl of 
buffer (3.1 or CutSmart®), 0.5 μl of 5’ restriction enzyme, 0.5 μl of 3’ restriction 
enzyme, 2μl plasmid and 15μl of nuclease-free water.  For the digestion of FastBac 
vector, 1μl of Antarctic phosphatase was added to 14μl of nuclease-free water, and 
other reagents were added as described.  The reactions were incubated at varying 
temperatures (according to the restriction enzyme used) for 2 hours.  Products were 
extracted and purified from a 2% agarose gel as previously stated in 2.5. 
2.10  DNA Assembly 
The NEBuilder® HiFi DNA Assembly Cloning Kit (NEB) was used to assemble 
DNA fragments in a ligation reaction.  The assembly reaction required the following 
reagents: 5μl of DNA product; 10μl of master mix and 5μl of nuclease-free water. 
For the assembly of 4-6 DNA fragments, the reactions were incubated at 50°C for 60 








 3. Kobuvirus 
The primary aims for the KoV section of the project was to sequence the full bovine 
KoV genome from a diarrhoeic calf, in order to assemble the genome for future virus 
challenge studies. 
3.1  Results 
3.1.1  Bovine kobuvirus PCR optimisation  
3.1.1.1  Sample selection and PanKobu Screening 
Previous work identified KoV in the faeces of calves with clinical enteritis and 
diarrhoea (Gregory et al. 2015, manuscript submitted).  The Pan-KoV primers that 
were used in this surveillance study were designed from a selection of GenBank 
human, bovine, porcine, ovine and murine sequences.  In order to better characterise 
the strain of bovine KoV present, the faecal samples from diarrhoeic calves were 
used again to amplify the full genome of the virus.  
The cDNA reverse transcribed from these samples was carried out with two separate 
primers: one with random hexamers and the other with 3’ GeneRacer (GR) primer. 
The random hexamers produced N6 cDNA by random binding throughout the 
genome, while 3’ GeneRacer primer produced GR cDNA which includes the polyA 
and some sequence prior to it on the 3’ strand.  The N6 cDNA was used to generate 
the first fragment, and GR cDNA was used to amplify the other three fragments. 
3.1.1.2  Bovine KoV PCRs targeting specific genome fragments 
A combination of bovine, porcine and/or ovine full genome sequences (GenBank 
numbers: NC_004421.1; NC_011829.1; KC204684.1; GU292559.1; KJ452348.1; 
KF539763.1; KC424640.1; KC424639.1; KC424638.1; JX177612.1; NC_016769.1; 
JQ692069.1; JN630514.1; GQ249161.1; KF695124.1; GU245693.2) were used to 
design primer sets (sense, S and antisense, AS) for amplification of the full bovine 
KoV genome (Figures 10 and 11.  Four PCRs were designed to cover the genome 
(excluding the 5’ end) comprising of 57-1898 (57S and 2908AS hemi-nested with 
57S and 1898AS); 1577-5260 (1577S and 5260AS), 4695-6714 (2883S and GR 
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nested with 4695S and 6714AS) and 6638-GR nest (6638S and GR hemi-nested with 
6638S and GR nest).  
 
Figure 10: The four regions PCR primers were designed to amplify, spanning the length of the 
genome (Region 1: 57-1898; region 2: 1577-5260; region 3: 4695-6714 and region 4: 6638-GR nest).  
The orange band represents the 1-1597 PCR that failed to amplify the appropriate product. 
 
 
Figure 11: The primers used to amplify the KoV genome, as designed from bovine, ovine and 







When designing primers the criteria below were followed, where possible (advised 
by Life Technologies): 
1. The length of between 18-25 nucleotides. 
2. Annealing temperature of primer pairs to be 50-55°C. 
3. GC content was between 50-65% with 3 GC in the first and last five 
nucleotides. 
4. Avoid repeats of 4 or more bases. 
 
Originally, LongAmp polymerase was used in the reactions targeting the four 
fragments, however, proof-reading taq polymerases (Herculase II, AccuPrime and 
Phusion) were used in later PCRs.  SequalPrep is a non-proof-reading taq 
polymerase, and was the second option for the initial PCRs if LongAmp was not 
working efficiently, for example in the generation of the 6638-GR nest fragment.  
3.1.1.3  Fragment 1-1597 
This PCR was designed to specifically include the 5’ end of the genome in the 
resulting fragment.  The reagent and conditions information can be found in Table 14 
(Appendix). 
Initially, the PCRs produced three faint products of the appropriate size (1.6kb), as 
shown in Figure 12B which were extracted, purified and cloned (methods 2.5 and 
2.7).  The consequent colony screen for these products (Figure 13) produced 
numerous amplicons for each colony with the faint products at 1.8kb being the 
appropriate size and more unexpected products at 950bp.  This colony screen was 
repeated (Figure 14) as the appropriately sized amplicons were much fainter than the 
other product.  The amplicons in lanes 11 and 12 of Figure 13 were the expected 
size, however, following extraction, purification and sequencing of the amplicons 
they were found to be bacterial contamination and so were not included in the SSE 







Figure 12: A 1-1597 PCR 1
st
 round and B nested 2
nd
 round.  Lanes 1-8 are calves 1-8, respectively.  
Products in lanes 3, 5 and 6 in B were extracted and purified for cloning. 
 
 
Figure 13: Colony Screen for 3 cloned amplicons described in Figure 12, with lanes 1-7 representing 





Figure 14: Colony screen repeat of Figure 13.  Lanes 1-3 are from product 3, 4-11 are product 5 and 
12 and 17 are product 6. 
3.1.1.4  Fragments 57-1898, 1577-5260 and 4965-6714 
From the primers that were designed, the following PCRs were carried out to obtain 
several clones for each fragment spanning the genome.  Following the unsuccessful 
1-1597 PCR the 57-1898 PCR was designed to use in its place.  For these three 
segments of the genome, LongAmp PCR reactions were performed with the reagent 
quantities and conditions in Table 15 (Appendix).  
Reactions with cDNA template from the faeces of calves 1, 7 and 8 produced 
amplicons of appropriate size (Figures 15 - 17).  The calf 1 reaction consistently 
produced an intense amplicon for each of the three PCRs whereas calf 7 produced 
weaker amplicons for the 1577-5260 and 4695-6714 PCRs, and calf 8 produced a 
weaker amplicon for the 57-1898 PCR.  The products for the 3 calves were extracted, 
ligated into pGEM®-T Easy Vector and transformed into DH5-α cells (methods 2.7). 
Following the colony screen, colonies were selected for plasmid extraction to 










 rounds for calves 1, 7 and 8.  The arrow indicates 
strong positive amplicons for calves 1 and 7, with a weak product for calf 8.  The 2
nd
 round 




Figure 16: 1577-5260 PCR for calves 1-8 with the arrow indicating the appropriate size product for 




Figure 17: 4695-6714 PCR 2
nd
 round for calves 1-8 (indicated by lanes 1-8). The arrow represents 
the appropriate size product of 2.3kb.  The remaining lanes on the gel are unrelated samples. 
 
3.1.1.5  Fragment 6638-GR nest  
The 6638-GR nest fragment was attempted with LongAmp taq polymerase, along 
with the other three fragments, however, a product of appropriate size could not be 
detected.  The PCR was repeated using SequalPrep taq polymerase with the reagents 
and conditions found in Table 16 (Appendix), and an amplicon of appropriate size 
was produced and cloned (Figure 18). 
 
Figure 18: 6638-GR nest PCR with the arrow indicating expected size products for calves 1, 7 and 8.  
These products were extracted, purified, cloned and sequenced.  The product for calf 4 was not 
investigated further as the other PCRs were unsuccessful with this calf. 
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A review of the cloned amplicons is presented in Table 6.  Given the success of calf 
1 cDNA in producing all four fragments, these PCR products were used to create the 
full genome, and a selection of the PCRs repeated using a proof-reading taq 
polymerase. 
Table 6: The number of clones produced for the calves 1, 7 and 8 for each genome fragment, 
following the first PCRs. 
 Clones 
Calf 57-1898 1577-5260 4695-6714 6638-GR nest 
1 1.1, 1.2, 1.3 1.1, 1.2, 1.3 1.1, 1.2, 1.3 1.1, 1.2, 1.3 









8.1, 8.2, 8.3 
 
3.1.1.6  5’ end amplification 
The final part of the BKoV genome to amplify was the 1-50bp region, following the 
difficulty optimising the 1-1597 PCR previously mentioned.  The GeneRacer™ Kit 
(Invitrogen) was used to target this region with primers designed from the U-1 BKoV 
and calf 1 57-1898 clone sequences.  The 391AS and 156AS primers were used in a 
hemi-nested PCR with the 5’ end primer included in the kit, the result of which can 
be seen in Figure 19.  From the gel image it is apparent this method was unable to 





Figure 19: 3’ nested PCR with 391AS and 3’ (1
st
 round) and 3’ nest and 156AS (2
nd
 round).  Lane 1 is 
the 1
st
 round reaction and lane 2 is the 2
nd






3.1.1.7  Proof-reading PCRs  
In order to confirm the accuracy of amplicons generated using LongAmp and 
SequalPrep taqs, Herculase II taq polymerase was used to repeat the same four 
fragment PCRs for calf 1.  As shown in Table 7, Herculase II taq polymerase has a 
10x higher fidelity than GoTaq, therefore the sequences from these clones would be 
more representative of the KoV present in the sample. 
Table 7: Comparison of the fidelities of taq polymerases used for generating KoV genome 
fragments. *compared to GoTaq (1x10
-5 
errors/base). **with Enhancer A. 
Taq polymerase Fidelity* 
LongAmp 2x 
SequalPrep Long 3.6x** 
Herculase II 10x 
 
 
Herculase PCRs were performed with the same primers in the first and second 
rounds and with the same reagents/quantities as in the LongAmp PCRs previously 






Table 8: Details of the Herculase PCRs showing variations in conditions and starting cDNA. 








1 57-1898 50°C 2 min N6 1.9Kb 
2 4695-6714 50°C 3 min GR 2.3Kb 
3 6638-GR 
nest 
55°C 2 min GR 1.9Kb 
4 1577-5260 55°C 4 min N6 3.8Kb 
5 4695-6714 55°C 3 min GR 2.3Kb 
 
From the amplicons shown in Figure 20, the amplicons in lane 1, 2 and 4 indicated 
by the arrows were extracted, purified, cloned and sequenced (methods 2.5 and 2.7).  
The 1577-5260 sequencing reaction failed to produce any sequence and therefore 
was not taken any further.  As the calf 1 57-1898 and 4695-6714 fragments were able 
to be generated using Herculase II taq polymerase, these same fragments for calves 7 
and 8 were targeted with the same reagents and conditions including the 50°C 
annealing temperature (Table 17 in the Appendix).  The calf 8 57-1898 and calf 7 
4695-6714 fragment PCRs are shown in Figure 21.  The amplicons indicated by the 
arrows were extracted, ligated into pCR®Blunt II-TOPO® vector and transformed 
into DH5-α cells.  After incubation of the plates, the calf 7 4695-6714 transformation 
failed to produce any colonies.  The successful Herculase PCRs were added to clones 
previously collected (Table 6) to make the final collection of clones from calves 1, 7 
and 8 (Table 9).  
 












PCRs.  Lanes 1 
and 2 are 1
st
 rounds and lanes 3 and 4 are 2
nd
 round reactions.  The amplicons indicated by the 
arrows were extracted, purified and sent for sequencing, although they were both negative for 
KoVs. 
Table 9: Final collection of clones produced from PCRs, with the addition of the Herculase PCRs 
(indicated in red). 
 Clones 
Calf 57-1898 1577-5260 4695-6714 6638-GR nest 
1 H1, 1.1, 1.2, 
1.3 
1.1, 1.2, 1.3 H1, 1.1, 1.2, 
1.3 
1.1, 1.2, 1.3 
7 7.1, 7.2, 7.3 - - 7.1, 7.2, 7.3 
8 - 8.1 - 8.1, 8.2, 8.3 
 
The calf 1 genome comprised of four fragments spanning from nucleotide 57 on the 
U-1 KoV genome to the 3’ polyA, with overlaps of 300-600bp to ensure one 
complete genome is assembled without combining separate KoVs from mixed 
infections.  The next steps for these clones was the assembly of an infectious clone 
and to compare the sequenced genome to the U-1 strain and other mammalian KoVs. 
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3.1.2  Genome assembly and comparison of VP1 regions 
3.1.2.1 Sequence assembly  
Following the generation of cloned fragments of calf 1, 7 and 8 genomes, the SSE 
alignment was used to assemble the sequence reads of each fragment obtained 
through primer walking.  Primer sites were removed and complete fragments were 
aligned, where possible, observing the main regions of diversity between the same 
fragment for each calf (e.g. 57-1898).  This alignment revealed diversity in the 
overlapping regions between fragment sequences, for example with the 57-1898 and 
1577-5260 overlap in Figure 22.  The calf 7 57-1898 fragment had a 100% identity 
to the calf 1 1577-5260 fragment in the overlapping region and the Herculase 57-
1898 fragment.  For this reason the Herculase 57-1898 fragment was selected for the 
KoV genome in place of the more diverse calf 1 57-1898 fragment.  The remaining 
fragments from calf 1 were used, including the Herculase 4695-6714 fragment 
instead of the LongAmp fragments for this region.  The plasmids used for the 
genome were as follows: Herculase calf 1 57-1898; LongAmp calf 1 1577-5260 1.2; 
Herculase calf 1 4695-6714; and LongAmp calf 1 6638-GR nest 1.3. 
Figure 22: SSE alignment comparing the calf 1 and 7 57-1898 sequences with the calf 1 1577-5260. 
The selected fragments for the complete genome were assembled using the same 
method as for the assembly of the sequence reads to form each fragment.  Where 
sequence errors occurred between the overlapping sequence reads of a fragment, the 
most common base between the reads was selected.  The completed genome was 
named BKoV_UK_SC1 and submitted to GenBank (GenBank number: KT003671) 
and will appear in the Gregory et al. 2015 paper (manuscript submitted).  Completion 
of the genome enabled its comparison with the U-1 strain and other Aichivirus B 
KoVs via a maximum likelihood phylogenetic recombination tree calculated using 




Figure 23: Phylogenetic relationship of BKoV_UK_SC1 (KT003671) compared to other known KoVs.  
The coloured boxes separate the genomes into their Aichivirus groups: red is Aichivirus A; blue is 
Aichivirus B; green is Aichivirus C. Caprine KoV has not yet been classified, although it was found to 
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3.1.2.2  Pairwise distance analyses  
Pairwise distance analyses were performed using the SSE alignment program and 
numerous sequences from the GenBank database.  The comparison graph in Figure 
24 represents the amino acid difference between the bovine KoV (NC_004421.1; 
KT003671) and a selection of porcine KoV (JX401523.1; JX177612.1; 
NC_011829.1; NC_016769.1; JQ692069.1; JN630514.1) and Aichi virus 
(NC_001918.1; GQ927711.2; GQ927705.2; GQ927712.2; GQ927706.2; 
GQ927704.2) genomes.  Porcine and bovine KoVs have a higher amino acid 
similarity to each other than either do to Aichi virus.  It is important to note that 
although the Vero cell culture the U-1 strain was isolated from contained fetal bovine 











Figure 24: Pairwise distance comparison of bovine KoV, porcine KoV and Aichi virus human 
genomes according to amino acid sequences. 
The same genome sequences used in Figure 24 were also used to produce the 
pairwise distance graph in Figure 25, directly comparing the BKoV_UK_SC1 strain 
in this study to the U-1 strain, the porcine KoVs and the Aichi viruses previously 
listed.  It is clear from this group there is a high amino acid similarity between the 
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BKoV_UK_SC1 and U-1 strain, compared to the other porcine and human 
sequences. 
 
Figure 25: Pairwise distance comparison between U-1 strain and BKoV_UK_SC1; porcine KoVs and 
BKoV_UK_SC1; BKoV_UK_SC1 and Aichi viruses, according to amino acid sequences. 
3.1.2.3  Assembly of the bovine KoV genome 
When preparing the plasmids selected to assemble the complete genome, the 
Herculase calf 1 57-1898 and 4695-6714 were unable to be recovered in sufficient 
quantity.  In their place the LongAmp calf 7 57-1898 plasmid 7.3 and LongAmp calf 
1 4695-6714 plasmid 1.1 were used as these clones shared an identical sequence with 
the Herculase fragments.  The NEBuilder® HiFi DNA Assembly Cloning Kit (NEB) 
suggested small overlaps between 15 and 80bp were most effective with this kit, 
therefore the NEB cutter tool V2.0 (NEB) tool was used to identify restriction sites 
on the 5’ and 3’ ends of each fragment with the aim of reducing the overlap size to 
between the recommended range.  The restriction enzymes selected for each 
fragment are shown in Table 10. 
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Table 10: The restriction enzymes selected for each genome fragment with the relevant buffer, 







Product sizes (Kb) 
57-1898 Xbal GQ/ 
BciVI 
CutSmart® 37°C 0.6, 0.9, 1.0, 1.2, 1.7 
1577-
5260 
SfcI/ AhdI CutSmart® 37°C <1, 1.2, 3.2 
4695-
6714 
BsrDI/ BsmBI 3.1 55-65°C (1 
hour at each) 










Figure 26: Bovine KoV fragments restriction digest.  Lane 1: 57-1898, lane 2: 1577-5260, lane 3: 
4695-6714 and lane 4: 6638-GR nest.  Amplicons indicated by green arrows were extracted and 
purified.  The orange arrow represents the expected size for the 4695-6714 fragment. 
The restriction digest of the four fragments was carried out (methods 2.9), and 
produced the amplicons visualised in Figure 26.  The appropriate amplicons were 
produced for the 57-1898, 1577-5260 and 6638-GR nest fragments, however, the 
4695-6714 fragment didn’t appear to have been cut on this gel.  This fragment digest 
was repeated with the 1.2 plasmid, which then produced the correct sized amplicon.   
The extracted products were purified and taken into the NEBuilder® HiFi DNA 
Assembly Cloning Kit. (methods 2.10).  
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The assembly reactions included a mix containing each of the following plasmids: 1 
and 2; 2 and 3; 3 and 4; 1, 2, 3 and 4.  These assembly reactions were used as the 
template for the PCRs in Figure 27.  The arrows for lanes 1-4 indicate the expected 
sizes for the amplicons, therefore only the 1-2 and 2-3 assembly mixes were 
successful.  Lanes 5-8 show the same PCR primers and conditions as lanes 1-4 but 
with the 1, 2, 3, 4 assembly mix.  As the same result was gained by both starting 
templates, this suggests there was something wrong with the overlap between 
fragments 3 and 4, rather than there being a PCR error or fault with the starting 
assembly mix.  There was a faint product at approximately 500bp in lane 4.  As this 
amplicon should have been 400bp and the product’s intensity is poor no further 




Figure 27: PCRs testing the success of the assembly reaction, using the primers in the table to 
amplify the overlapping regions of the assembly mixes.  The pink arrows indicate the appropriate 
size products.  Amplicons of the appropriate size were extracted from lanes 2, 3, 6 and 7. 
Lane Assembly Primers 

















3.1.2.4  VP1 protein amplification  
In total, 9 VP1 (3650-3940) sequences were generated from diarrhoeic calves on 
farms in Ayrshire and Dumfries.  These included calves 1 and 8 that have been 
previously mentioned, along with 7 others from the other farms in South West 
Scotland.  These were compared to the VP1s of the U-1 strain (NC_004421.1), other 
bovine KoVs (from the Chang et al. 2014 study)( KF728711.1; KF728712.1; 
KF728713.1; KF728714.1; KF728715.1; KF728715.1; KF728716.1; KF728717.1; 
KF728718.1; KF728719.1; KF728720.1; KF728721.1; KF728722.1; KF728723.1; 
KF728724.1; KF728725.1; KF728726.1; KF728727.1) and porcine KoVs 
(JX401523.1; JX177612.1; NC_011829.1; NC_016769.1; JQ692069.1; JN630514.1) 
(Figure 28).  The maximum likelihood tree shows the expected separation of bovine 
KoVs from the other kobuvirus species.  The bovine KoVs from the Chang et al. 
study can be divided into 2 lineages, with an additional VP1 forming a separate 





 Bovine KoV VP1 m
 Bovine KoV VP1 n
 Bovine KoV VP1 l
 Bovine KoV VP1 k
 Bovine KoV VP1 j
 Bovine KoV VP1 o
 KT003671 Bovine KoV UK SC1
 Calf 1 plasmid 1
 Bovine KoV VP1 i
 NC 004421.1 Bovine KoV U-1
 KF728727.1 Aichivirus B X1-143
 KF728721.1 Aichivirus B GN1155
 KF728722.1 Aichivirus B X3-4
 KF728723.1 Aichivirus B X3-14
 KF728724.1 Aichivirus B X3-23
 KF728725.1 Aichivirus B X3-77
 KF728726.1 Aichivirus B X3-78
 KF728711.1 Aichivirus B H5
 KF728716.1 Aichivirus B H16
 KF728713.1 Aichivirus B H8
 KF728712.1 Aichivirus B H7
 KF728714.1 Aichivirus B H9
 KF728715.1 Aichivirus B H13
 KF728718.1 Aichivirus B H19
 KF728717.1 Aichivirus B H18
 KF728719.1 Aichivirus B H23
 KF728720.1 Aichivirus B H29
 JX177612.1 Porcine KoV WB-1-HUN/2011/HUN
 NC 016769.1 Porcine KoV SH-W-CHN/2010/China
 JN630514.1 Porcine KoV SH-W-CHN/2010/China
 JX401523.1 Porcine KoV CH/HNXX-4/2012
 NC 011829.1 Porcine KoV S-1-HUN/2007/Hungary
 JQ692069.1 Porcine KoV WUH1
0.5  
Figure 28: VP1 comparison between the 9 VP1s in this study, the U-1 strain and other bovine KoVs 
from Chang et al. 2014.  This maximum likelihood tree is based on the 3650-3940 region of the VP1 
protein. Circles in green indicate novel sequences generated in this study, while those in red are 






3.2  Discussion 
3.2.1 cDNA synthesis and cloning of bovine KoV genome 
Of the total 64 KoV positive calves in the Gregory et al. study (2015, manuscript 
submitted), 8 diarrhoeic calves’ samples were selected for genome amplification in 
order to generate and assemble a full genome from an infected individual.  Specific 
PCRs were designed to target four overlapping regions of the ~8Kb genome.  The 
number of fragments to divide the genome was decided to enable quick, efficient 
optimisation of PCRs to generate the products, while also remaining low to aid the 
assembly of the genome.  Excluding fragment 1577-5260, the PCRs were nested or 
hemi-nested to improve specificity, having found a one round PCR not to be 
sufficient to produce the appropriate size product. Primer sites were selected to share 
large overlapping regions between fragments, allowing the genome assembly from 
generated sequences to produce a sequence representative of a single virus, rather 
than a chimeric one due to a mixed infection.  Large overlaps would also allow a 
greater range of assembly cloning kits to potentially be used.  The primer pairs 
chosen for PCR, shown in Figure 10, were designed from the bovine, some porcine 
and/or ovine full KoV genome sequences available from GenBank.  Where possible, 
the primers were designed according to the criteria set out, to ensure time and 
resources were not wasted on primers that were unlikely to amplify the template.  
Due to the nature of bovine KoV, in that there is only one reference genome, 
sometimes primers did not work effectively, despite fitting the criteria previously 
indicated.  
Originally, the 1-1597 fragment was targeted for amplification, although this primer 
set failed to amplify the appropriate product (Figures 12-14).  The colony screen 
produced by the three weak amplicons in Figure 12, was repeated due to the poor 
intensity of the appropriate sized amplicon and the high intensity of another 
amplicon. As there should only be one product present in a colony screen if the 
ligation and transformation has worked effectively, the extracted products were 
ligated and transformed again.  This repeated colony screen did produce intense 
amplicons of appropriate size, suggesting the problem that had occurred with the first 
colony screen had been resolved.  Once extracted and sequenced the two amplicons 
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from the second colony screen (11 and 12) either produced failed sequences, or were 
positive for bovine KoV U-1 strain but matched a region of the genome of 
approximately 5.1Kb.  For this reason a new PCR was designed to ensure the 
appropriate product covering the first ~2Kb of the genome would be amplified. 
The four PCRs (described as 57-1898, 1577-5260, 4695-6714 and 6638-GR nest) 
were carried out on cDNA, after the reverse transcription of RNA extracted from 8 
calves’ faecal samples.  When the 57-1898 PCR was designed to replace the 1-1597 
PCR, the 57s primer covered the first available sequence without multiple base 
repeats and that was not as GC rich as the 1s primer sequence.  The antisense primer 
for this fragment was also designed to have a large (~300bp) overlap with the second 
fragment, to enable virus-specific assembly of the genome at a later date.  The PCR 
conditions used to amplify the fragments were initially based on the manufacturers’ 
protocols (found in the methods section), with small changes made throughout the 
course of the study to optimise the conditions for each fragment PCR.  The 
LongAmp taq polymerase worked for the 57-1898, 1577-5260 and 4695-6714 
fragments.  However, the 6638-GR nest fragment required optimisation with 
SequalPrep taq polymerase to amplify the product (Figure 16).  From these gel 
images, the calves with the most successfully amplified fragments were AstVs from 
calves 1, 7 and 8.  Therefore these became the focus for completing the genome.  
LongAmp and SequalPrep taq polymerases were most commonly used in this project 
as they have been the preferred taqs used in this lab.  LongAmp taq polymerse was 
used first to generate each fragment, then SequalPrep was used if this was 
unsuccessful. 
Following insertion of these PCR products in pGEM-T-Easy or pCR-blunt II-TOPO 
vector, internal sequencing was carried out with M13 primers and the original 
primers used to generate the fragments.  Internal primers were then designed from 
the sequences obtained (Table 5) allowing full sequencing of the 1.9-3.8Kb 
fragments.  Numerous primers were designed to overlay throughout the genome, 
particularly in the overlapping regions, to ensure the base and amino acid sequence 
was without sequencing errors and to allow primer walking.  Initial generation of 
fragments did not produce all four for the calves 1, 7 and 8.  The weaker amplicons 
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observed in Figures 15-17 for calves 7 and 8 may have been as a result of 
mispriming or variations in sequence, not taken into account with primer design.  
The selection of primers to target a region, which in most cases had only one bovine 
reference sequence, meant unexpected variations in these regions would either 
reduce the number of copies produced or prevent amplification altogether.  This 
could be the reason calves 2-6 were often unsuccessful.  Repeat PCRs of these 
fragments were difficult with only small amounts of original cDNA available and 
calf-specific primers required to target the varied regions.  For this reason calf 1 
became the main focus for the full genome.   
The Generacer™ Kit (Invitrogen) was used to generate the 5’ end with bovine-
specific primers (conserved from the bovine U-1 strain), however, this was unable to 
amplify the appropriate product (Figure 19).  Secondary and tertiary structures have 
been detected at the 5’ end of other KoV species.  The GC-rich nature has previously 
made it difficult for other researchers to amplify and sequence this region (Sasaki et 
al. 2001; Yamashita et al. 2003; Martínez-Salas et al. 2015).  This has not, however, 
been verified in bovine KoVs to date.  If this method was to be repeated, a proteinase 
K digestion would be carried out before the kit protocol to remove the VPg and any 
other unknown structures, enabling the kit to work more effectively.  As this 1-50bp 
region is required for virus replication, it will be synthesised separately and ligated 
onto the completed genome to function as an infectious clone at a later date. 
The proof-reading Herculase taq polymerase was used with the aim of reducing the 
likelihood of sequences containing errors, compared to those found in sequences 
produced by the other taq polymerases used (Table 7), thus producing a KoV 
genome with the highest amino acid identity to the one originally detected in the 
faecal sample.  Maintaining a high amino acid identity is important when producing 
an infectious clone, to ensure it will replicate and interact in the same way in virus 
challenge studies as in the infected animal.  While the 57-1898 and 4695-6714 calf 1 
fragments were able to be amplified with Herculase taq polymerase, 57-1898 and 
4695-6714 from other calves and the other two fragments from calf 1 were 
unsuccessful.   
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3.2.2  Genome assembly and comparison of VP1 regions 
Phylogenetic identity to the known bovine KoV strain (U-1) and other mammalian 
KoVs was calculated, the results of which can be seen in Figure 23.  The Aichivirus 
B group (highlighted in blue) includes the U-1 strain, ovine and ferret KoVs, thought 
as candidate species to be in the Aichivirus B group (Cho et al. 2015).  The 
Aichivirus A and C groups also include the expected species, with murine KoV, 
canine KoV, feline KoV and Aichi virus in the former, and porcine KoV in the latter 
(Ribeiro et al. 2013; Cho et al. 2015).  The recent discovery of caprine KoV, situated 
between Aichivirus groups B and C, has not yet been classified.  The KoV genome 
from this study was submitted to GenBank with the title BKoV_UK_SC1 and 
accession number KT00367.  As shown in Figure 23, the BKoV_UK_SC1 genome is 
most closely related to the U-1 bovine KoV strain (GenBank number: 
NC_004421.1).  While this may not seem surprising as several of the primers were 
designed using the U-1 strain, BKoV_UK_SC1 showed a 91% similarity to the U-1 
strain, which is less than that found between other species such as porcine and canine 
KoV.  This suggests there is great variation in bovine KoVs compared to KoVs of 
any other species.  The second closely related KoV is the ovine KoV (ADG03747.2) 
with a similarity of 81%. 
Using an SSE alignment containing the bovine U-1, six porcine and six Aichi virus 
genomes, pairwise-distance graphs were generated showing the a) amino acid 
difference within each Aichivirus species compared to each of the other two groups 
(Figure 24), b) amino acid difference between the BKoV_UK_SC1 genome and the 
U-1, porcine and Aichi virus genomes individually (Figure 25).  Although there are 
several more than six genomes available from GenBank for Aichi virus and porcine 
KoV, they are shown to group closely together in Figure 23 so six genomes would be 
representative of the species.  From the first comparison (Figure 24), the bovine and 
porcine genome amino acid sequences are more closely related than the bovine and 
Aichi virus genomes, which are the most diverse out of the Aichivirus species.  This 
is consistent among the three groups.  There are two main regions where this can be 
seen are: ~350-400aa and ~1500aa.  Using Figure 10 as a reference for the genome, 
positions 1, 3 and 5 on Figure 24 are the most diverse regions of the genomes for all 
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three species.  These regions correspond to the L protein, VP1 and 3B regions, 
respectively, which have been previously acknowledged as the most diverse regions 
of the KoV genome.  The L protein is thought to play a role in RNA replication and 
encapsidation; the VP1 has been found it be most immunogenic; while the exact 
function of the 3B protein is currently undetermined (Sasaki et al. 2003).  The points 
2, 4 and 6 correspond to the VP0, 2C and 3D regions, respectively, which are 
typically the most conserved KoV proteins.  VP0 is cleaved into VP4 and VP2 
situated in the capsid; 2C is vital for the formation of viral replication vesicles; and 
the 3D protein codes for a RNA polymerase (common among Picornaviridae) 
(Yamashita et al. 1998; Dietz et al. 2000).  
The second comparison graph (Figure 25) shows the amino acid difference between 
the BKoV_UK_SC1 genome and the bovine U-1, porcine KoV and Aichi virus 
genomes.  The comparison between the U-1 and BKoV_UK_SC1 genomes show 
they are very similar in terms of amino acid sequence, with the L and 2B proteins 
showing the greatest diversity.  The trend of this graph and that of Figure 24 is 
similar for the BKoV_UK_SC1 vs. porcine KoV and Aichi virus, with the same 
regions showing the highest and lowest regions of diversity.  There is, however, a 
point at approximately 500aa which shows a higher amino acid diversity between the 
BKoV_UK_SC1 and porcine KoV genomes, which corresponds to the 2B protein.  
The 2B protein is known to alter host cell membrane permeability (Dietz et al. 2000), 
which could equate to one of either BKoV_UK_SC1 or the U-1 strain playing a 
greater role in diarrhoeal disease than the other.  Having few bovine KoV genomes 
available for analysis, or even partial genomes covering the P1 and P2 segments of 
the genome, means comparisons of pathogenicity are difficult to confirm.  The 
source of the U-1 strain as a contaminant of Vero cell culture, possibly from the fetal 
bovine serum used, means there is no background information on the animal or 
group of animals from which it originated. 
Comparison of the two bovine KoV genomes in both Figures 24 and 25, proves to be 
diverse from the Aichi viruses included in the sample group for comparison.  There 
has not at present been any cause for concern regarding the zoonotic potential of 
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bovine KoV, and the distance between the Aichi viruses seen here and current bovine 
genomes available supports this.  
In preparation for the assembly of the full genome, each of the four fragments 
underwent a restriction digest at both ends to produce a linearised KoV fragment 
separated from the vector.  The NEBuilder® HiFi DNA Assembly Cloning Kit was 
chosen to assemble the genome in preference over other cloning methods such as the 
Gibson Assembly® Cloning Kit.  Reasons for this decision include the higher 
accuracy and more colonies associated with using the NEBuilder® HiFi DNA 
Assembly Cloning Kit.  Also, this master mix can join DNA fragments together more 
efficiently, even with larger fragments of low DNA inputs, and is a high-fidelity 
assembly.  It is important a high fidelity kit was used to prevent errors being 
introduced at this later stage, having undertaken measures to reduce errors 
throughout the study.  When selecting the most appropriate sites (see Table 10), the 
optimum overlap criteria included in the NEBuilder® HiFi DNA Assembly Cloning 
kit manual was taken into account, therefore overlaps were cut back accordingly. 
The restriction digest was initially successful for the 57-1898, 1577-5260 and 6638-
GR nest fragments (Figure 26).  The 4695-6714 fragment may not have been cut on 
the first attempt as two incubation temperatures were required for both of the 
restriction enzymes selected to function.  Once repeated with an overnight incubation 
the digest was successful, suggesting the previous 2 hour incubation was insufficient 
to cut the desired product.  
Assembly of the genome using the NEBuilder® HiFi DNA Assembly Cloning Kit 
was effective for ligating fragments 1 and 2, and 2 and 3 together (shown in Figure 
27).  For both the assembly reactions using the 3/4 and 1/2/3/4 assembly mixes, the 
3/4 PCR was unsuccessful as were the 57-GR and 57-GR nest PCR reactions.  The 
GR nest primer was used in the second set of assembly reactions as the 6638-GR nest 
PCR was a hemi-nested PCR with the GR nest primer in the second round.  It was 
originally thought the first 57-GR assembly reaction failed for this reason.  However, 
the second assembly reaction proves that was not the case.  The reason this assembly 
failed would appear to be as a result of the 3/4 assembly also failing to ligate, as this 
assembly reaction did not work with either of the two assembly mixes used.  The 57-
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GR was incubated at 50°C for 60 minutes as detailed in the manufacturer’s protocol 
for 4-6 fragments, however, due to the size of the final assembled fragment a longer 
incubation period may have also been necessary.  The 4695-6714 and 6638-GR nest 
fragment sequences were checked for the necessary restriction sites which were 
present, and at the expected bases in the sequence. The restriction buffers and 
conditions were also checked.  As the LongAmp 4695-6714 1.1 plasmid was 
originally used in the restriction digest, unsuccessfully, the 1.1 plasmid may have 
accidentally been used in the assembly mix rather than the 1.2 plasmid that was used 
to repeat the restriction digest and produce the appropriate products.   
The VP1 region of the KoV genome is a logical choice for measuring diversity 
within and between the species, as it is recognised as the most diverse of the three 
capsid regions.  Capsid diversity can reveal crucial information about both host-
pathogen interactions and their ability to survive in the environment, which can lead 
to better control measures and animal management to reduce the impact of viral 
disease.  The neighbour-joining method was used to generate the VP1 comparison 
tree (Figure 28) because it was appropriate to show the diverse lineages between the 
bovine KoVs and porcine KoVs.  While whole genome comparisons are difficult for 
the reasons previously explained, one Chinese study by Chang et al. (2014) 
investigated VP1 diversity in their sample set and were able to sequence 17 VP1 
proteins.  From the tree, two main lineages can be observed from the published 17 
VP1 regions of bovine KoVs, and a further lineage including 1 VP1 from the Chang 
et al. study, the U-1 VP1 and the 9 VP1s, from this study.   While these sequences 
have been separated into lineages, the diversity between the bovine VP1 sequences is 
much lower than expected.  This may be due to the relatively low number of VP1 
sequences available or that bovine KoVs have more conserved VP1 regions 
compared to other KoV species.  It is also important to consider the other proteins in 
the KoV genome which have been found to be highly diverse among porcine KoVs 
and Aichi viruses: the L protein and 3B protein.  As most published bovine KoV 
sequences are from the detection of the virus, they are usually fragments of the RdRp 
region and are therefore highly conserved.  The sequencing of more full bovine KoV 
genomes would provide more insight into the regions of highest diversity in the 
bovine KoV genome. 
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4  Astrovirus 
The aims for the AstV section of this project were to sequence and prepare bovine 
AstV capsids, in order to express their proteins in baculovirus.  An ELISA could then 
be developed to enable detection of AstV antibodies in bovine serum, useful for 
further investigation into their role in calf diarrhoea. 
4.1  Results 
4.1.1  RdRp and Capsid Analysis 
4.1.1.1  Bovine astrovirus PCRs targeting the RdRp and capsid regions  
Two PCRs were designed to sequence the whole genome (56-_AS, nested from 56-
3862 (from Sharp et al. 2015), and 2312-GR nest, nested from 2312-GR, see Figures 
29-32).  The 56-_AS PCR and 2312-GR nest PCR reagent quantities and conditions 
can be found in Tables 10 and 11 in the Appendix, respectively.  The 2312-GR nest 
PCR aimed to amplify the RdRp and capsid proteins, while the 56-_AS PCR targeted 
the ORF1a and RdRp segments.  The 56S and 2312S primers were designed from 
four published bovine AstV sequences: B170/HK, B76/HK, B18/HK and B76-2/HK 
(GenBank numbers: NC_023632.1; NC_023629.1; NC_023631.1; NC_023630.1), as 
shown in Figure 30.  The 3862s and 3882AS primers were designed from the 52 
nucleotide conserved region found immediately upstream of the ORF1b/ORF2 




Figure 29: PCR regions in relation to the bovine AstVs genome: 56-_AS (green); 2312-GR nest (pink) 
and 3862-GR nest (purple). 
 
 
B170/HK  TACATCAATCGTGCTGACGAGGC 
B76/HK  TACATCAACCGTGCTGACGAGGC 
B18/HK   TACATCAACCGTGCTGACGAGGC 




B170/HK  AACAACGGCCCCAGAAATCCAC 
B76/HK  AACAACGGCCCCAGAAATCCAC 
B18/HK   AACAGCGGCCCCAGAAATCCAC 








Figure 31: LongAmp 56-3862 (blue) and 2312-GR nest (pink) 1
st
 (lanes 1-16) and 2
nd
 (lanes 17-32) 
round PCR, on calves 1-8.  The 56-3862 PCR was nested with 56s and _AS, and the 2312-GR nest 
PCR was nested with IAS1, IAS2 and GR nest. 
 
Figure 32: SequalPrep 56-_AS (blue) and 2312-GR nest (pink) 1
st
 (lanes 1-16) and 2
nd
 (lanes 17-32) 
round PCR, on calves 1-8. 
The LongAmp 56-_AS PCR in Figure 31 was unable to amplify the appropriate size 
product, therefore the focus turned to optimising the 2312-GR nest PCR to include 
the RdRp and capsid proteins within the same PCR product (Tables 18 and 19 in the 
Appendix).  This would allow RdRp sequences previously amplified from this 
sample set to be analysed and separated into lineages showing the extent of diversity 
of the AstVs detected.  The SequalPrep 2312-GR nest PCR produced 2 amplicons of 
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the appropriate size, one 1
st
 round (lane 13) and one 2
nd
 round (lane 29), while the 
56-_AS PCR produced 8 amplicons of expected size, 4 1
st
 round (lanes 1, 3, 5 and 6) 
and 4 2
nd
 round (lanes 17, 19, 21 and 22) (Figure 32).  These products were extracted 
and purified. Sequencing confirmed that the 56-_AS amplicons 3, 5, 13 and 19 were 
bovine AstV.  Sequencing reactions were also performed on 2312-GR nest 
amplicons but did not produce readable data.  Amplicons 13 and 29 were cloned into 
pGEM®-T easy vector but only amplicon 29 produced colonies with an 
appropriately sized screening PCR (methods 2.7) product.  Sequencing of this 
product with M13 primers proved it to be a bacterial contaminant.  
Following this difficulty generating the 2312-GR nest fragment, it was decided that 
previously cloned capsid sequences would be used for the generation of expression 
constructs. 
4.1.1.2  Neuro AstV 
During this project some pig brain samples became available to test for neuro AstVs, 
with an additional cow brain sample positive for bovine neuro AstV used as a 
control.  The PanAstro primers (used in Sharp et al. 2015) were used in a PCR with 
the conditions from the Chu et al. 2008 paper.  Details can be found in Table 20 of 
the Appendix.  While the appropriate size amplicon for the pig sample in lane 3 was 
negative for AstV (Figure 33), the bovine neuro AstV positive control was extracted 
and cloned for restriction digest and ligation into FastBac at a later date.  
 
Figure 33: Neuro AstVs PCR targeting pig samples (lanes 1-3) and using a bovine neuro AstV as a 
positive control (lane 4).  The products in lanes 3 and 4 were extracted, purified, cloned and sent 
for sequencing (methods sections 2.5-2.7). The pig sample in lane 3 was negative for AstVs. 
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4.1.2  Capsid analysis and cloning into FastBac 
4.1.2.1  Capsid analysis 
Prior to this project, another member of the research group (Bill Gregory) had 
developed a capsid PCR to gain as many AstV capsids from the diarrhoeic and non-
diarrhoeic calves as possible.  He then cloned the capsids using the methods detailed 
earlier in this thesis (methods 2.7). 
In Figure 34, the RdRp lineages (assigned in the Sharp et al. 2015 study) and the 
capsid lineages from the same sample set can be compared.  While the coloured lines 
show the RdRp sequences matched to the calf cDNA they originated from, they 
cannot be matched to individual capsid clones as these were generated at a later date.  
None of the capsid sequences matched with RdRp sequences from lineage 2.  As 
more calves were targeted for RdRp sequences previously, there are more calves 
represented in the RdRp tree than the capsid tree which explains why there are no 
capsid sequences matched to RdRp lineage 2. 
The calf 2 AstV capsids (lineage 4), in Figure 35, appear to be diverse from the other 
AstV capsids from other calves, which is also suggested in Figure 34.  The AstV 
capsids appeared to form four lineages as indicated in Figure 35, however, the 
pairwise distance comparison of capsid amino acid sequences suggested there were 
just two distinct capsid lineages, one of which could be separated into three clades.  
From the pairwise-distance comparison in Figure 36, lineage 4 is the most diverse 
compared to the other three lineages as the neighbour-joining tree in Figure 35 
suggests.  According to ICTV’s 2011 AstV report, the mean amino acid genetic 
distances (p-dist) requires a range of 0.378-0.750 between groups to be counted as 
separate species.  Lineage four has a mean pairwise distance of between 0.562-0.644 
making it a separate species compared to the pairwise distances of the other three 
lineages by the ICTV criteria.  However, mean pairwise distances for the other 
lineages are as follows: 1 v 2 is 0.356; 1 v 3 is 0.347 and 2 v 3 is 0.305.  
Consequently, none of the other three lineages have a large enough mean pairwise 
distance to qualify as being separate species according to the ICTV criteria.  Figure 
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36 suggests capsids labelled lineages 1 and 2 are more closely related to each other 








Figure35: Phylogenetic relationships between AstV capsids sequenced in this study and a selection 




Figure 36: Pairwise-distance comparison of the four lineages in Figure 31, using amino acid 
sequences. 
4.1.2.2 Cloning AstV capsids into FastBac 
Primers were designed to add restriction sites to the capsids using the capsid 
plasmids as the PCR template (Table 11).  Due to the previous design of primers, the 
capsid sequences were 13 nucleotides short of the full capsid seen in the B18/HK, 
B170/HK and BAstGX-G1 sequences (Figure 37).  Therefore this conserved short 
sequence was to be added to the forward primer and presumed the same for the 
capsid sequences in this study.  Using the NEB cutter tool V2.0 (NEB), the RsrII and 
SalI restriction sites were identified either side of the insert region in the FastBac 
vector.  The PCR primers, 3748s and 5970AS, were designed to include the missing 
13 nucleotides and the RsrII and SalI restriction sites attached at the 5’ and 3’ ends, 
respectively.  Long and short versions of the 3748s+RSrlI were designed to ensure 
there was enough capsid sequence overlap before the restriction site to allow binding.  
Details of these primers can be found in Table 12. 
Herculase II Fusion DNA Polymerase (Agilent) was used to generate this product in 
a reaction detailed in Table 21 in the Appendix.  In total, 16 capsids from 7 different 
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calves were included in the restriction site PCR.  Details of the capsids used can be 
found in Table 11. 
Table 11: The clones produced from the healthy and diarrhoeic samples, with their capsid names 
for reference.  The clones in red were not available in sufficient quantities for restriction digest. 
Calf number Clone names 
Calf 2 1.2, 1.4, 1.5 
Calf 3 2.11, 2.22, 2.8 
Calf 4 18, 19, 20 
Case 2 25, 26 
Case 3 33, 34, 35 
Case 5 3 
Healthy calf 8 41, 42, 43 
 
 
Figure 37: SSE alignment showing the missing 13 nucleotides from the capsid sequences that were 
added to the primer sequences. 
Table 12: Sequence details for the primers used in the 3748-5970 restriction site PCR.  In bold is the 




























Figure 38: Herculase 3748s-5970 capsid region PCR with RsrII and SalI restriction sites.  Lanes 1-17 
represent the reactions carried out with BAstVCap 3748s+RsrII short primer, and lanes 18-34 
represent those with BAstVCap 3748s+RsrII long primer.  Lanes 14 and 31 were negative controls. 
 
The 3748s+RsrII long primer was able to amplify the fragment more effectively than 
the shorter version of the primer and therefore it was these products that were 
extracted (Figure 38).  Amplicons in lanes 21-30 and 32-34 were extracted, purified 
and ligated into the pCR™-Blunt II-TOPO® vector.  The calf 2 products were also 
extracted, purified and sequenced.  When the BLAST analysis was first carried out 
only 20bp of the ~350bp sequence was positive for bovine AstV, and so was not 
included in the restriction digest.  These sequences were checked again at a later date 
and recently added sequences to GenBank were a match for the full ~350bp sequence 
analysed.  These capsids can be processed further at a later date to be included in the 
baculovirus expression.  
The capsids cloned from Figure 38 underwent the restriction digest with RsrII and 
SalI.  Details of the restriction digests can be found in Table 22 in the Appendix. 
Initially the digest was carried out as a double-cut with both restriction enzymes in 
the same mix, however, this was unsuccessful as Figure 39 shows the plasmids were 
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uncut.  The digest was repeated by first cutting with SalI in buffer 3.1 with a 100µl 
reaction, then extracting and purifying the products (eluting with water rather than 
elution buffer).  The purified products were cut with the RsrII enzyme, the results of 
which are shown in Figure 40.  Case 2 plasmids 25 and 26; calf 4 plasmid 20 and 
healthy calf 8 plasmids 42 and 43 were successfully cut with RsrII and SalI.  The 
FastBac vector also underwent a restriction digest with RsrII and SalI 
These five capsids were cloned into the cut FastBac vector, and the colony screen 
was successful for case 2 plasmid 26; calf 4 plasmid 20 and healthy calf 8 plasmids 
42 and 43.  These four plasmids were then extracted from cultures of these positive 
clones using the QIAprep Miniprep kit (Qiagen).  Figure 35 shows the positions of 
the four capsids within the four lineages containing the capsid amino acid sequences 
from this study.  
 




Figure 40: Sequential digest with SalI then RsrII.  The appropriate size products (middle product 
indicated by the arrow) were extracted from lanes 11-14. 
Table 13: PCR primers used to target the complete bovine KoVs and AstVs genomes. 




1S Sense 27 TTTGAAAAGGGGGTGGGGGGGCTTCGG 
156AS Antisense 22 GGCGAGAAAGTACCAAGAGGAC 
92AS Antisense 22 ACGCAGTAGCACTTCCGCACCG 
1577S Sense 23 AAMCAYTGGTGGGAACCTGCTGC 
1597AS Antisense 23 CGTCGTCCAAGGGTGGTYACMAA 
1898AS Antisense 21 GGCTCCTGGACACTTTCGAGT 
4695S Sense 25 TGGTSATMATCTGTGCKGATCTKGC 
5260AS Antisense 25 AGCCAAGCAGGGATTTCCCAGTGCC 
57S Sense 22 GTTCGCGTCGTCGTAAGTCTGG 
6638S Sense 25 CYTYGAGGGTMTSTGTGGTGCTWCC 
6714AS Antisense 21 TCTTCCTTAAACACAACAAGG 
GR Antisense 25 GCTGTCAACGATACGCTACGTAACG 
GR nest Antisense 23 CGCTACGTAACGGCATGACAGTG 
PanKobu_IAS Antisense 24 ATGATGGTGTTRAKGATRGARGTG 
PanKobu_IS Sense 22 TGGAYTACAAGTGYTTTGATGC 
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PanKobu_OAS Antisense 23 GTGTCNGGRTCCATSACHGGGTG 
PanKobu_OS Sense 21 GTGGTTGAGGCAGCTCCAGTG 
Astrovirus 
2312S Sense 22 AACARCGGCCCCAGAAATCCAC 
56S Sense 23 TACATCAACCGTGCTGAYGAGGC 
3862s Sense 21 TCRTCTTTGGAGGGGAGGACC 
3717S Sense 20 GAGCATGGCCGCTCCTTGCC 













Antisense 28 CCGTCGACCTACAGCCCCATGGCATAGC 
PanAstro_IAS1 Antisense 20 CGKTAYGATGGKACKATHCC 
PanAstro_IAS2 Antisense 20 AGGTAYGATGGKACKATHCC 
PanAstro_IS Sense 22 TGGAYTACAAGTGYTTTGATGC 
PanAstro_OS1 Sense 23 GARTTYGATTGGRCKCGKTAYGA 






4.2  Discussion 
AstV diversity has been well recognised within the literature with the capsid proteins 
showing highest diversity compared to the ORF1a or ORF1b (RdRp) regions.  As 
with KoV and other viruses, the capsid is often the most diverse segment of the 
genome in order to be able to adapt to the host environment.  Studying capsid 
diversity gives insight into the host-pathogen interactions resulting in infection; 
potential differences in pathogenicity between AstVs and how adult cattle gain 
acquired immunity to the AstVs they come into contact with. 
4.2.1  RdRp Capsid diversity 
Initial PCRs targeted the complete coding region of the genome for amplification.  
As this would be able to highlight all regions of diversity throughout the genome, 
any highly diverse regions in the ORF1a or RdRp segments may explain why some 
AstV co-infections result in more severe diarrhoea than others.  Another focus for 
targeting the complete coding region was to get the RdRp and capsid from each 
AstV.  Previous RdRp from the Sharp et al. study (2015) and capsid sequences, were 
obtained from multiple animals but it could not be assumed the RdRp and capsid 
sequences were from the same AstV, with many calves being co-infected.  Difficulty 
generating the 2312-GR nest fragment with both LongAmp and SequalPrep taqs 
meant this was unfortunately not possible with the PCR reagents and conditions 
used.  Following sequencing with M13 primers, the SequalPrep colony screen 
amplicon produced in Figure 32 was found to be bacterial contamination.  Although 
the amplicon in Figure 31 extracted for the colony screen was the expected amplicon 
size, using faecal samples for PCR can lead to bacterial contaminants from the 
sample being amplified and cloned instead of the targeted AstV, particularly when 
using degenerative primers as is the case here.  SequalPrep taq polymerase was used 
after the LongAmp PCR was unsuccessful, because it has a high amplification 
success rate for long range PCR and is reported to require less optimisation than the 
LongAmp taq polymerase.  This PCR may have been unsuccessful for several 
reasons, for example the PCR spanned a 4Kb region of the genome of both highly 
conserved and highly diverse sequence.  While the RdRp region is the most 
conserved AstV fragment, this is relative to the remaining of the AstV genome, with 
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few 18-25bp sections with appropriate GC content at the start of the RdRp for a 
primer to target.  The 2312 site was the most suitable choice for a primer, without 
making the PCR product much larger.  The decision was then made to focus on the 
capsid PCR as this would still enable diversity between capsids, and then between 
RdRp and capsid groups, to be compared.  
Matching up the RdRp and capsid sequences in Figure 34 demonstrates the diversity 
between the RdRp and capsid lineages from the AstV capsids sequenced.  It is worth 
noting there are more RdRp than capsid AstV sequences, which is due to the success 
of the RdRp PCR for more calf samples than the capsid PCR.  The capsids 
(excluding calf 2) primarily match with the RdRp lineage 3, with just one capsid 
sequence from case 3 matching with an RdRp from lineage 1.  The diversity of calf 2 
capsids to the AstVs of other calves suggests these capsid sequences would match 
RdRp lineage 1.  The main purpose of generating these two neighbour-joining trees 
was to ensure capsids representative of multiple viral lineages (based on RdRp 
phylogeny) were selected for use in the baculovirus expression system. 
The neuro AstV PCR in Figure 33 produced the appropriate size amplicon for one of 
the pig samples and the bovine positive control using the reagents and conditions in 
Table 20 of the Appendix.  While the porcine amplicon sequence did not match any 
AstV sequences when entered into BLAST, the bovine positive control was 
sequenced and matched the Bovine AstV NeuroS1 sequence with 94-99% nucleotide 
identity.  The 3129-GR nest capsid PCR will be performed on the bovine neuro AstV 
positive sample, then cloned and treated the same as the other AstV capsids.  With 
the recent discovery of neuro AstVs, little is known about epidemiology and 
geographical distribution of this group of AstVs in the UK.  The bovine neuro AstV 
capsid will also be expressed in baculovirus to produce proteins that can be used to 
test bovine serum for antibodies against the virus. 
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4.2.2  Capsid selection for cloning with restriction sites 
Cloning capsids into baculovirus using the Bac-to-Bac® baculovirus expression 
system would allow the production of virus-like particles, which can be used to 
detect the presence of antibodies in bovine serum.  This technique has been effective 
for human and avian AstVs, and has led to the production of a diagnostic ELISA and 
potentially antivirals for avian AstV in chickens (Caballero et al. 2004; Lee et al. 
2013; Skibinska et al. 2015).  Restriction sites for the capsids were selected from 
those available in the FastBac vector, at the 5’ and 3’ ends of the insert site, and the 
sites were searched for in the AstV capsid sequences to ensure the capsid would not 
be cut during restriction digest. 
Initially, the 3748-5970 restriction site PCR was carried out on all of the capsids in 
Table 11, excluding capsids 33, 41 and 1 as an insufficient amount of these plasmids 
could be recovered.  Multiple clones were included from each calf to increase the 
likelihood of at least one of the clones for each calf producing the appropriate 
amplicon.  The calf 2 capsids produced amplicons much larger than the expected size 
(approximately 1.5Kb larger).  However, as mentioned previously in the results 
section, GenBank sequences later became available which had a high identity to the 
~350bp capsid sequence analysed.  The 3748-5970 PCR was repeated on calf 2 
capsids, and the result was the same.  As plasmid DNA was used as template in these 
PCRs and the inserts had been sequenced in full, the reason for this is unknown.  The 
restriction digest of the capsids with RsrII and SalI, was originally carried out with 
both enzymes in the same reaction with buffer 3.1.  However, the capsids were only 
cut once indicating one of the enzymes were not working effectively (Figure 39). 
This may have been unsuccessful because the CutSmart buffer is recommended for 
use with the RsrII enzyme, rather than the buffer 3.1 used.  Repetition using a 
sequential digest, with SalI first, was successful for 5/18 capsids from 3 calves (2 





5  Future work 
Progress made during this project in the genetic characterisation and analysis of 
bovine KoV and bovine AstV, has both continued the work of previous studies and 
provided the foundation data for future exploration into the replication and 
pathogenesis of these two viruses.  The project aimed to sequence the full bovine 
KoV genome from one animal and produce an infectious clone to be used in future 
challenge studies.  While bovine AstV capsids required full sequencing and 
preparation for use in the baculovirus expression system, in order to develop 
serological techniques.  
Continuing on from this study there are both virus-specific and, more generally, calf 
diarrhoea developments to be made in order to broaden the knowledge of these 
viruses and their role as a primary pathogen or a co-factor in diarrhoeal disease.  
Firstly, the KoV part of the project, has additional work to be done on the production 
of a complete infectious clone.  At present the 57-1898, 1577-5260 and 4695-6714 
fragments are assembled, but the 6638-GR nest fragment and first 50bp of the 
genome are not ligated to the 5’ and 3’ ends of the assembled sequence.  Virus 
produced from this infectious clone can be used in challenge studies to investigate its 
impact and role in calf diarrhoea.  It is important to find out if bovine KoV is truly 
pathogenic in the absence of other known enteric pathogens. 
Finishing the genome of viruses from calves 7 and 8 and any gaps in these genomes 
would increase the number of reference genomes available for comparison.  
Producing multiple infectious clones, including those from healthy animals, would 
allow for differences in pathogenicity depending on strain of bovine KoV to be 
studied.  Detection of bovine KoV neutralising or recognising antibodies in cattle 
would also confirm whether immunity is acquired in infected calves and determine 
whether this persists to adulthood. 
Following the previous work comparing VP1 proteins in KoVs extracted from 
infected calves in the Chang et al, 2014 study and the attempts to amplify the same 
region in this study, this PCR should be optimised and performed on the cDNA of 
the 99 KoV-positive calf faecal samples stored.  This would enable the comparison 
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of a much larger sample set, producing a more representative conclusion of the 
lineages formed and the true diversity of bovine KoVs in the field.  Epidemiology 
studies could also use this information to examine the prospect of geographical 
subtypes of the virus and possible recombination events. 
Further work on the AstV part of the project would include cloning broader diversity 
of capsids (including those from neurotropic viral species), and using the virus-like 
particles in ELISAs to detect the presence of antibodies in bovine serum.  This would 
enable more representative epidemiological studies of AstV in the UK, as well as 
investigating how healthy calves shed AstV in their faeces without any clinical signs.  
Also, there may be differences in the prevalence of each capsid lineage in different 
areas of the UK, or some lineages more associated with aiding other enteric 
pathogens during co-infections, e.g. rotavirus. 
The 3748-5970 capsid PCR should be performed on the bovine neuro AstV positive 
control used with the pig samples, in order to fully sequence the capsid of this AstV.  
As the prevalence of neuro AstVs across the world is unknown, testing for antibodies 
in cattle blood serum would provide a foundation for further study in transmission, 
replication and pathogenesis of this virus.  
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6  Conclusion 
This project used genetic characterisation and sequence analysis to investigate the 
role of bovine KoVs and AstVs in calf diarrhoea using a sample set from diarrhoeic 
and non-diarrhoeic calves.  A key aim was to produce outcomes which could then be 
used to develop serological assays and virus clones in preparation for further 
investigation of prevalence and pathogenicity. 
The full KoV genome (BKoV_UK_SC1) was sequenced and submitted to GenBank 
under the accession number KT003671.  Following pairwise distance analysis, this 
genome had a high amino acid identity to the bovine U-1 strain and the VP1 protein 
could be identified as the principal region of the highest diversity between these 
genomes.  Partial VP1 sequences of 8 diarrhoeic animals were successfully generated 
and compared to the BKoV_UK_SC1 and U-1 genomes.  A high nucleotide identity 
between these VP1 sequences compared to those from the Chang et al. study was 
unexpected, although additional full VP1 sequences should be generated before a 
reliable conclusion can be formed.  At present, the 57-6714 section of the KoV 
genome has been successfully assembled with the 1-56 and 6638-GR nest fragments 
to be added at a later date.  
AstV capsid clones from 7 diarrhoeic and non-diarrhoeic calves were sequenced, and 
compared to other bovine AstV capsids by phylogenetic analysis.  The generated 
capsid clones were representative of two RdRp and two capsid lineages by ICTV 
criteria.  Attempts to clone the AstV capsids into the FastBac vector were successful 
for 4 capsid clones (20, 26, 42 and 43), which will be sub-cloned and expressed in 
baculovirus for the expression of capsid proteins.  The bovine neuro AstV clone and 
calf 2 capsid clones will be cloned into the FastBac vector to enable further studies of 
AstV diversity and prevalence in the British cattle population.  
In conclusion, this project has provided some fundamental tools to investigate KoV 
prevalence and pathogenicity in diarrhoeic animals; AstV diversity and its role in 
mixed enteric pathogen infections and the prevalence of the recently discovered 





7  Appendix 
Table 14: The quantities of reagents used in the 1-1597 PCR with the relevant conditions.  *the 
1597AS primer was used in the second round PCR. 
 
 
Table 15: The quantities of reagents used in the 57-1898, 1577-5260 and 4695-6714 PCRs with 













Table 17: Conditions for the 57-1898 and 4695-6714 Herculase PCRs. 
 









Table 19: The quantities of reagents and relevant conditions used in the 2312-GR nest PCR.  
*GR primer used in first round, and GR nest primer used in the second round. 
 
 
Table 20: Reagent quantities and conditions used to perform the neuro AstV PCR. *40 rounds 
of amplification were used for the second round PCR. 
 
 
Table 21: The reagent quantities and conditions used in the 3748-5970 restriction site 







Table 22: The buffers and conditions used for the restriction digests, and the estimated product 









SalI 3.1 37°C 16 hours 
2.5, 2.2, 2 
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